☰

Ju-I Kao, Ed.D. - Publications

Affiliations: 
2003 University of South Dakota, Vermillion, SD, United States 
Area:
Higher Education
Tree Info Similar researchers PubMed Report error

390 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Hsu YC, Tseng CH, Su TH, Kao JH, Nguyen MH. Pooling data to assess risks and benefits of discontinuing nucleos(t)ide analogs in patients with chronic hepatitis B: challenges and opportunities. Gut. PMID 34670810 DOI: 10.1136/gutjnl-2021-326232  0.311
2021 Cheng HR, Yang HC, Lin SR, Yang TY, Lin YY, Su TH, Tseng TC, Liu CJ, Kao JH. Correction to: Combined viral quasispecies diversity and hepatitis B core-related antigen predict off-nucleos(t)ide analog durability in HBeAg-negative patients. Hepatology International. PMID 34562189 DOI: 10.1007/s12072-021-10245-z  0.325
2021 Huang SC, Kao JH. Strategies for hepatitis C virus treatment failure. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 34538553 DOI: 10.1016/j.jfma.2021.09.004  0.307
2021 Huang SC, Cheng PN, Liu CH, Yang HC, Su TH, Tseng TC, Chen PJ, Kao JH, Liu CJ. Serum cytokine/chemokine profiles predict hepatitis B reactivation in HBV/HCV co-infected subjects receiving direct-acting antiviral agents. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 34538552 DOI: 10.1016/j.jfma.2021.09.002  0.388
2021 Yeh ML, Hung CH, Tseng KC, Lai HC, Chen CY, Kuo HT, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Tai CM, Lin CW, Kao JH, et al. Long-term outcome of liver complications in patients with chronic HBV/HCV co-infection after antiviral therapy: a real-world nationwide study on Taiwanese Chronic Hepatitis C Cohort (T-COACH). Hepatology International. PMID 34365587 DOI: 10.1007/s12072-021-10220-8  0.424
2021 Kao JH, Jeng WJ, Ning Q, Su TH, Tseng TC, Ueno Y, Yuen MF. APASL guidance on stopping nucleos(t)ide analogues in chronic hepatitis B patients. Hepatology International. PMID 34297329 DOI: 10.1007/s12072-021-10223-5  0.368
2021 Liu CH, Chen CY, Su WW, Liu CJ, Lo CC, Huang KJ, Chen JJ, Tseng KC, Chang CY, Peng CY, Shih YL, Huang CS, Kao WY, Yang SS, Tsai MC, ... ... Kao JH, et al. Sofosbuvir/velpatasvir plus ribavirin for Child-Pugh B and Child-Pugh C hepatitis C virus-related cirrhosis. Clinical and Molecular Hepatology. PMID 34255961 DOI: 10.3350/cmh.2021.0155  0.363
2021 Lee WC, Chen TK, Han HF, Lin YC, Hwang YM, Kao JH, Chen PJ, Liu CJ. Investigating the prevalence and clinical effects of hepatitis delta viral infection in Taiwan. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. PMID 34162528 DOI: 10.1016/j.jmii.2021.03.014  0.3
2021 Hsu WF, Tsai PC, Chen CY, Tseng KC, Lai HC, Kuo HT, Hung CH, Tung SY, Wang JH, Chen JJ, Lee PL, Chien RN, Lin CY, Yang CC, Lo GH, ... ... Kao JH, et al. Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (T-COACH). Journal of Gastroenterology and Hepatology. PMID 33963615 DOI: 10.1111/jgh.15538  0.392
2021 Liu CH, Chen PY, Chen JJ, Lo CC, Su WW, Tseng KC, Liu CJ, Huang CS, Huang KJ, Yang SS, Peng CY, Tsai MC, Kao WY, Chang CY, Shih YL, ... ... Kao JH, et al. Sofosbuvir/velpatasvir for patients with chronic hepatitis C virus infection and compensated liver disease: real-world data in Taiwan. Hepatology International. PMID 33677787 DOI: 10.1007/s12072-021-10158-x  0.399
2021 Chen CY, Huang CF, Cheng PN, Tseng KC, Lo CC, Kuo HT, Huang YH, Tai CM, Peng CY, Bair MJ, Chen CH, Yeh ML, Lin CL, Lin CY, Lee PL, ... ... Kao JH, et al. Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C - a real-world nationwide HCV Registry Program (TACR) in Taiwan. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 33655714 DOI: 10.1111/liv.14849  0.387
2021 Hsieh MH, Bair MJ, Tsai PC, Tseng KC, Lo CC, Chen CY, Kuo HT, Hung CH, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, ... ... Kao JH, et al. Long-term risk of end stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in Taiwan. Journal of Gastroenterology and Hepatology. PMID 33624849 DOI: 10.1111/jgh.15469  0.326
2021 Wu JW, Kao JH, Tseng TC. Three Heads are Better than Two: HBcrAg as a New Predictor of HBV-related HCC. Clinical and Molecular Hepatology. PMID 33618507 DOI: 10.3350/cmh.2021.0012  0.36
2021 Tseng TC, Choi J, Nguyen MH, Peng CY, Siakavellas S, Papatheodoridis G, Wang CC, Lim YS, Lai HC, Trinh HN, Wong C, Wong C, Zhang J, Li J, Kao JH. One-year Fibrosis-4 index helps identify minimal HCC risk in non-cirrhotic chronic hepatitis B patients with antiviral treatment. Hepatology International. PMID 33547557 DOI: 10.1007/s12072-020-10124-z  0.358
2021 Tseng TC, Liu CJ, Yang WT, Hsu CY, Hong CM, Su TH, Tsai CH, Chen CL, Yang HC, Liu CH, Chen HH, Chen PJ, Kao JH. Serum hepatitis B core-related antigen level stratifies risk of disease progression in chronic hepatitis B patients with intermediate viral load. Alimentary Pharmacology & Therapeutics. PMID 33465271 DOI: 10.1111/apt.16266  0.421
2021 Liu CH, Chen CY, Su WW, Tseng KC, Lo CC, Liu CJ, Chen JJ, Peng CY, Shih YL, Yang SS, Huang CS, Huang KJ, Chang CY, Tsai MC, Kao WY, ... ... Kao JH, et al. Sofosbuvir/velpatasvir with or without low-dose ribavirin for patients with chronic hepatitis C virus infection and severe renal impairment. Gut. PMID 33408122 DOI: 10.1136/gutjnl-2020-323569  0.334
2021 Liu M, Tseng TC, Jun DW, Yeh ML, Trinh H, Wong GLH, Chen CH, Peng CY, Kim SE, Oh H, Kwak MS, Cheung M, Toyoda H, Hsu YC, Jeong JY, ... ... Kao JH, et al. Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients. Hepatology International. PMID 33394321 DOI: 10.1007/s12072-020-10113-2  0.32
2021 Lin C, Kao J. Prevention of hepatitis B virus-related hepatocellular carcinoma Hepatoma Research. 2021. DOI: 10.20517/2394-5079.2020.125  0.346
2021 Park J, Le A, Tseng T, Yeh M, Jun DW, Trinh HN, Wong GL, Chen C, Peng C, Kim SE, Kwak M, Toyoda H, Hsu Y, Jeong JY, Yoon E, ... ... Kao J, et al. 510 PROGRESSION OF CHRONIC HEPATITIS B TO CIRRHOSIS AND HEPATOCELLULAR CARCINOMA BY AGE, SEX, DISEASE ACTIVITY, AND TREATMENT STATUS USING AASLD CRITERIA Gastroenterology. 160: S-786. DOI: 10.1016/S0016-5085(21)02594-4  0.317
2020 Tsai PC, Chen CY, Kuo HT, Hung CH, Tseng KC, Lai HC, Peng CY, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Kao JH, Liu CJ, et al. Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH). Open Forum Infectious Diseases. 7: ofaa397. PMID 33376753 DOI: 10.1093/ofid/ofaa397  0.335
2020 Cheng YM, Tzeng IS, Kao JH, Wang CC. Author reply to letter to the editor "The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma". Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 33358562 DOI: 10.1016/j.jfma.2020.12.016  0.302
2020 Chen CL, Kuo MJ, Yen AM, Yang WS, Kao JH, Chen PJ, Chen HH. Gender Difference in the Association Between Metabolic Factors and Hepatocellular Carcinoma. Jnci Cancer Spectrum. 4: pkaa036. PMID 33134821 DOI: 10.1093/jncics/pkaa036  0.354
2020 Wang CC, Tseng KC, Tzeng IS, Kao JH. The impact of cytokine change after hepatitis C virus clearance by direct antiviral agents on the risk of hepatocellular carcinoma. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 33129621 DOI: 10.1016/j.jfma.2020.10.015  0.329
2020 Yeo YH, Tseng TC, Hosaka T, Cunningham C, Fung JYY, Ho HJ, Kwak MS, Trinh HN, Ungtrakul T, Yu ML, Kobayashi M, Le AK, Henry L, Li J, Zhang J, ... ... Kao JH, et al. Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 Patients. Clinical and Translational Gastroenterology. 11: e00196. PMID 33094953 DOI: 10.14309/ctg.0000000000000196  0.317
2020 Yu ML, Tsai WL, Chu CJ, Kao JH. Characteristics of patients with hepatitis C virus infection and antiviral treatment initiation in Taiwan: The MOSAIC study. The Kaohsiung Journal of Medical Sciences. PMID 33089964 DOI: 10.1002/kjm2.12317  0.355
2020 Kao JH, Hu TH, Jia J, Kurosaki M, Lim YS, Lin HC, Sinn DH, Tanaka Y, Wai-Sun Wong V, Yuen MF. East Asia expert opinion on treatment initiation for chronic hepatitis B. Alimentary Pharmacology & Therapeutics. PMID 32951256 DOI: 10.1111/Apt.16097  0.34
2020 Chen PJ, Kao JH, Liu CJ, Yang HC. In memoriam: Dr. Ding-Shinn Chen, 1943-2020. Hepatology (Baltimore, Md.). PMID 32767845 DOI: 10.1002/Hep.31505  0.361
2020 Cox AL, El-Sayed MH, Kao JH, Lazarus JV, Lemoine M, Lok AS, Zoulim F. Progress towards elimination goals for viral hepatitis. Nature Reviews. Gastroenterology & Hepatology. PMID 32704164 DOI: 10.1038/s41575-020-0332-6  0.4
2020 Liu CH, Su TH, Liu CJ, Chen PJ, Chen DS, Kao JH. Sofosbuvir/velpatasvir/voxilaprevir plus ribavirin for chronic hepatitis C patients with direct acting antiviral failures: Implications for viral elimination in Taiwan. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32553687 DOI: 10.1016/j.jfma.2020.06.013  0.344
2020 Liu CH, Peng CY, Fang YJ, Kao WY, Yang SS, Lin CK, Lai HC, Su WP, Fang SU, Chang CC, Su TH, Liu CJ, Chen PJ, Chen DS, Kao JH. Elbasvir/grazoprevir for hepatitis C virus genotype 1b East-Asian patients receiving hemodialysis. Scientific Reports. 10: 9180. PMID 32513953 DOI: 10.1038/s41598-020-66182-8  0.358
2020 Su HJ, Kao JH, Tseng TC, Yang HC, Su TH, Chen PJ, Liu CJ. Pathologic findings of patients with nonalcoholic fatty liver disease and the impact of concurrent hepatitis B virus infection in Taiwan. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32499209 DOI: 10.1016/J.Jfma.2020.05.027  0.378
2020 Huang SC, Yang HC, Kao JH. Hepatitis B Reactivation: Diagnosis and Management. Expert Review of Gastroenterology & Hepatology. PMID 32448008 DOI: 10.1080/17474124.2020.1774364  0.373
2020 Tseng TC, Peng CY, Hsu YC, Su TH, Wang CC, Liu CJ, Yang HC, Yang WT, Lin CH, Yu ML, Lai HC, Tanaka Y, Nguyen MH, Liu CH, Chen PJ, ... ... Kao JH, et al. Baseline Mac-2 Binding Protein Glycosylation Isomer Level Stratifies Risks of Hepatocellular Carcinoma in Chronic Hepatitis B Patients with Oral Antiviral Therapy. Liver Cancer. 9: 207-220. PMID 32399434 DOI: 10.1159/000504650  0.347
2020 Chang WY, Chiu YC, Chiu FW, Hsu YC, Tseng TC, Cheng PN, Yang SS, Liu CJ, Su TH, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. High Risk of clinical relapse in HBV-infected patients after cessation of prophylactic antiviral therapy for rituximab-containing chemotherapy. The Journal of Infectious Diseases. PMID 32396638 DOI: 10.1093/Infdis/Jiaa256  0.365
2020 Lin CL, Kao JH. Hepatitis B: Immunization and Impact on Natural History and Cancer Incidence. Gastroenterology Clinics of North America. 49: 201-214. PMID 32389359 DOI: 10.1016/j.gtc.2020.01.010  0.334
2020 Yu ML, Chen PJ, Dai CY, Hu TH, Huang CF, Huang YH, Hung CH, Lin CY, Liu CH, Liu CJ, Peng CY, Lin HC, Kao JH, Chuang WL. 2020 Taiwan consensus statement on the management of hepatitis C: part (I) general population. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32359879 DOI: 10.1016/j.jfma.2020.04.003  0.361
2020 Yu ML, Chen PJ, Dai CY, Hu TH, Huang CF, Huang YH, Hung CH, Lin CY, Liu CH, Liu CJ, Peng CY, Lin HC, Kao JH, Chuang WL. 2020 Taiwan consensus statement on the management of hepatitis C: Part (II) special populations. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32354689 DOI: 10.1016/j.jfma.2020.04.002  0.4
2020 Hsu CS, Liu WL, Li Q, Lowey B, Hertz L, Chao YC, Liang TJ, Chen DS, Kao JH. Hepatitis C virus genotypes 1-3 infections regulate lipogenic signaling and suppress cholesterol biosynthesis in hepatocytes. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 32284164 DOI: 10.1016/J.Jfma.2020.03.018  0.343
2020 Huang CF, Lai HC, Chen CY, Tseng KC, Kuo HT, Hung CH, Wang JH, Chen JJ, Lee PL, Chien RN, Yang CC, Lo GH, Tai CM, Lin CW, Kao JH, et al. Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH). The American Journal of Gastroenterology. PMID 32221162 DOI: 10.14309/ajg.0000000000000606  0.405
2020 Nguyen MH, Wong G, Gane E, Kao JH, Dusheiko G. Hepatitis B Virus: Advances in Prevention, Diagnosis, and Therapy. Clinical Microbiology Reviews. 33. PMID 32102898 DOI: 10.1128/CMR.00046-19  0.407
2020 Tseng TC, Liu CJ, Chang CT, Su TH, Yang WT, Tsai CH, Chen CL, Yang HC, Liu CH, Chen PJ, Chen DS, Kao JH. HEV superinfection accelerates disease progression in patients with chronic HBV infection and increases mortality in those with cirrhosis. Journal of Hepatology. PMID 32006586 DOI: 10.1016/J.Jhep.2020.01.012  0.386
2020 Liu CH, Yang SS, Peng CY, Lin WT, Liu CJ, Su TH, Tseng TC, Chen PJ, Chen DS, Kao JH. Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection and severe renal impairment. Journal of Viral Hepatitis. PMID 31981264 DOI: 10.1111/jvh.13265  0.381
2020 Su TH, Chen CL, Kao JH. Letter: hepatitis B virus infection and risk of multiple myeloma-a meta-analysis of cohort studies. Authors' reply. Alimentary Pharmacology & Therapeutics. 51: 310-311. PMID 31880017 DOI: 10.1111/apt.15607  0.322
2020 Khalili M, Lampertico P, Bae HS, Ma X, Ramji A, Fung S, Ahn SH, Kao J, Tam E, Halton P, Yee L, Flaherty J, Gaggar A, Liu Y, Wu G, et al. S1070 A Phase 3 Study Comparing Switching: Tenofovir Disoproxil Fumarate (TDF) to Tenofovir Alafenamide (TAF) With Continued TDF Treatment in Virologically Suppressed Patients With Chronic Hepatitis B: Final Week 96 Results American Journal of Gastroenterology. 115: S543-S543. DOI: 10.14309/01.ajg.0000706328.53076.1a  0.328
2020 Chiu Y, Liu C, Liu C, Chen P, Chen D, Kao J. Sa1531 PERSISTENT ON-TREATMENT ALANINE AMINOTRANSFERASE ELEVATION (POAE) IN PATIENTS WITH CHRONIC HEPATITIS C RECEIVING INTERFERON (IFN) FREE DIRECT ACTING ANTIVIRALS (DAAS) Gastroenterology. 158: S-1322. DOI: 10.1016/s0016-5085(20)33976-7  0.361
2019 Liu CH, Lee MH, Lin JW, Liu CJ, Su TH, Tseng TC, Chen PJ, Chen DS, Kao JH. Evolution of eGFR in chronic HCV patients receiving sofosbuvir-based or sofosbuvir-free direct acting antivirals. Journal of Hepatology. PMID 31790766 DOI: 10.1016/j.jhep.2019.11.014  0.351
2019 Ogawa E, Toyoda H, Iio E, Jun DW, Huang CF, Enomoto M, Hsu YC, Haga H, Iwane S, Wong G, Lee DH, Tada T, Liu CH, Chuang WL, Hayashi J, ... ... Kao JH, et al. HCV Cure Rates are Reduced in Patients with Active but not Inactive Hepatocellular Carcinoma- A Practice Implication. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 31777940 DOI: 10.1093/cid/ciz1160  0.329
2019 Wang CC, Cheng PN, Kao JH. Systematic review: chronic viral hepatitis and metabolic derangement. Alimentary Pharmacology & Therapeutics. PMID 31746482 DOI: 10.1111/apt.15575  0.373
2019 Liu CH, Liu CJ, Hung CC, Hsieh SM, Su TH, Sun HY, Tseng TC, Chen PJ, Chen DS, Kao JH. Glecaprevir/pibrentasvir for patients with chronic hepatitis C virus infection: real-world effectiveness and safety in Taiwan. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 31710759 DOI: 10.1111/liv.14295  0.383
2019 Hsu SJ, Enkhzaya S, Lin YY, Tseng TC, Khosbayar T, Tsai CH, Wang TS, Enkhtuya D, Ivshinkhorol D, Naranzul N, Jargalsaikhan B, Amarsanaa J, Baatarkhuu O, Kao JH. Resistance-associated substitution and ledipasvir/sofosbuvir therapy in Mongolian chronic hepatitis C patients. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 31672433 DOI: 10.1016/j.jfma.2019.10.003  0.383
2019 Hsu SJ, Yang SS, Kao JH. Risk of hepatocellular carcinoma development after hepatitis C virus eradicated by direct-acting antivirals: Fact or fiction? Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 31627984 DOI: 10.1016/j.jfma.2019.09.006  0.391
2019 Su TH, Peng CY, Tseng TC, Yang HC, Liu CJ, Liu CH, Chen PJ, Chen DS, Kao JH. Serum Mac-2-binding protein glycosylation isomer at virological remission predicts hepatocellular carcinoma and death in chronic hepatitis B related cirrhosis. The Journal of Infectious Diseases. PMID 31574141 DOI: 10.1093/infdis/jiz496  0.344
2019 Kanda T, Lau GKK, Wei L, Moriyama M, Yu ML, Chuang WL, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Kadir Dokmeci A, Mamun-Al-Mahtab, ... ... Kao JH, et al. APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation. Hepatology International. PMID 31541423 DOI: 10.1007/s12072-019-09988-7  0.376
2019 Kao JH, Berg T. Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop? Gut. PMID 31527067 DOI: 10.1136/gutjnl-2019-319648  0.343
2019 Su TH, Yang HC, Tseng TC, Chou SW, Lin CH, Liu CH, Liu CJ, Chen CL, Kao JH. Antiviral Therapy in Patients With Chronic Hepatitis C Is Associated With a Reduced Risk of Parkinsonism. Movement Disorders : Official Journal of the Movement Disorder Society. PMID 31505068 DOI: 10.1002/Mds.27848  0.346
2019 Tseng TC, Liu CJ, Hsu CY, Hong CM, Su TH, Yang WT, Chen CL, Yang HC, Huang YT, Fang-Tzu Kuo S, Liu CH, Chen PJ, Chen DS, Kao JH. High Level of Hepatitis B Core-related Antigen Associated With Increased Risk of Hepatocellular Carcinoma in Patients With Chronic HBV Infection of Intermediate Viral Load. Gastroenterology. PMID 31470004 DOI: 10.1053/J.Gastro.2019.08.028  0.375
2019 Huang CF, Iio E, Jun DW, Ogawa E, Toyoda H, Hsu YC, Haga H, Iwane S, Enomoto M, Lee DH, Wong G, Liu CH, Tada T, Chuang WL, Cheung R, ... ... Kao JH, et al. Direct-acting antivirals in East Asian hepatitis C patients: real-world experience from the REAL-C Consortium. Hepatology International. PMID 31463665 DOI: 10.1007/s12072-019-09974-z  0.346
2019 Hsu SJ, Chiu MC, Fang YJ, Yang TH, Yu JJ, Chen CC, Kuo CC, Lee JY, Chen CH, Chen DS, Kao JH. Real-world effectiveness and safety of glecaprevir/pibrentasvir in Asian patients with chronic hepatitis C. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 31279502 DOI: 10.1016/j.jfma.2019.06.014  0.471
2019 Huang CF, Hung CH, Cheng PN, Bair MJ, Huang YH, Kao JH, Hsu SJ, Lee PL, Chen JJ, Chien RN, Peng CY, Lin CY, Hsieh TY, Cheng CH, Dai CY, et al. An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for treatment-naïve chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resistance-associated substitution. The Journal of Infectious Diseases. PMID 30957170 DOI: 10.1093/infdis/jiz154  0.398
2019 Liu CH, Shih YL, Yang SS, Lin CL, Fang YJ, Cheng PN, Chen CY, Peng CY, Hsieh TY, Chiu YC, Su TH, Liu CJ, Yang HC, Chen PJ, Chen DS, ... Kao JH, et al. Paritaprevir/ritonavir, ombitasvir plus dasabuvir for East-Asian non-cirrhotic hepatitis C virus genotype 1b patients receiving hemodialysis. Journal of Gastroenterology and Hepatology. PMID 30931537 DOI: 10.1111/jgh.14672  0.402
2019 Hsu YC, Tseng CH, Kao JH. Quantification of Hepatitis B Core Antibody Helps Predict Clinical Relapse After Cessation of Nucleos(t)ide Analogues in Chronic Hepatitis B Patients: More Needs to Be Done. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 17: 1000-1001. PMID 30902225 DOI: 10.1016/j.cgh.2018.09.002  0.359
2019 Wang CC, Kao JH. The role of hepatitis B surface antigen in nucleos(t)ide analogues cessation among Asian chronic hepatitis B patients: friend or foe? Hepatology (Baltimore, Md.). PMID 30703245 DOI: 10.1002/hep.30532  0.36
2019 Liu CH, Su TH, Liu CJ, Hong CM, Yang HC, Tseng TC, Chen PJ, Chen DS, Kao JH. Sofosbuvir-based direct acting antiviral therapies for patients with hepatitis C virus genotype 2 infection. Journal of Gastroenterology and Hepatology. PMID 30693965 DOI: 10.1111/Jgh.14615  0.388
2019 Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Chronic hepatitis B is associated with an increased risk of B-cell non-Hodgkin's lymphoma and multiple myeloma. Alimentary Pharmacology & Therapeutics. PMID 30681172 DOI: 10.1111/Apt.15132  0.323
2019 Yu M, Hung C, Cheng P, Bair M, Huang Y, Kao J, Shu S, Lee P, Chen J, Chien R, Peng C, Lin C, Hsieh T, Dai C, Huang J, et al. THU-195-An open-label, randomized, active control trial of 8 versus 12 weeks of elbasvir/grazoprevir for naive chronic hepatitis C genotype 1b patients with mild fibrosis (EGALITE): Impact of baseline viral loads and NS5A resitance-associated substitution Journal of Hepatology. 70: e248-e249. DOI: 10.1016/S0618-8278(19)30470-0  0.33
2018 Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Early antiviral therapy reduces the risk of lymphoma in patients with chronic hepatitis C infection. Alimentary Pharmacology & Therapeutics. PMID 30592071 DOI: 10.1111/Apt.15101  0.366
2018 Liu CH, Liu CJ, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Kao JH. Real-world effectiveness and safety of sofosbuvir and ledipasvir with or without ribavirin for patients with hepatitis C virus genotype 1 infection in Taiwan. Plos One. 13: e0209299. PMID 30576344 DOI: 10.1371/Journal.Pone.0209299  0.373
2018 Kanda T, Lau GKK, Wei L, Moriyama M, Yu ML, Chuang WL, Ibrahim A, Lesmana CRA, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Mamun-Al-Mahtab, ... ... Kao JH, et al. APASL clinical practice recommendation: how to treat HCV-infected patients with renal impairment? Hepatology International. PMID 30539517 DOI: 10.1007/s12072-018-9915-5  0.321
2018 Yu ML, Hung CH, Huang YH, Peng CY, Lin CY, Cheng PN, Chien RN, Hsu SJ, Liu CH, Huang CF, Su CW, Huang JF, Liu CJ, Kao JH, Chuang WL, et al. Efficacy and safety of 12 weeks of daclatasvir, asunaprevir plus ribavirin for HCV genotype-1b infection without NS5A resistance-associated substitutions. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 30527566 DOI: 10.1016/j.jfma.2018.11.007  0.348
2018 Chien RN, Kao JH, Peng CY, Chen CH, Liu CJ, Huang YH, Hu TH, Yang HI, Lu SN, Ni YH, Chuang WL, Lee CM, Wu JC, Chen PJ, Liaw YF. Taiwan consensus statement on the management of chronic hepatitis B. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 30527436 DOI: 10.1016/j.jfma.2018.11.008  0.361
2018 Liu CH, Yu ML, Peng CY, Hsieh TY, Huang YH, Su WW, Cheng PN, Lin CL, Lo CC, Chen CY, Chen JJ, Ma Q, Brooks-Rooney C, Kao JH. Real-world anti-viral treatment decisions among chronic hepatitis C patients in Taiwan: The INITIATE study. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 30448077 DOI: 10.1016/j.jfma.2018.10.020  0.335
2018 Yeo YH, Ho HJ, Yang HI, Tseng TC, Hosaka T, Trinh HN, Kwak MS, Park YM, Fung JYY, Buti M, Rodriguez M, Treeprasertsuk S, Preda CM, Ungtrakul T, Charatcharoenwitthaya P, ... ... Kao JH, et al. Factors Associated with Rates of HBsAg Seroclearance in Adults with Chronic HBV Infection: A systematic review and meta-analysis. Gastroenterology. PMID 30342034 DOI: 10.1053/J.Gastro.2018.10.027  0.351
2018 Hong CM, Liu CH, Su TH, Yang HC, Chen PJ, Chen YW, Kao JH, Liu CJ. Real-world effectiveness of direct-acting antiviral agents for chronic hepatitis C in Taiwan: Real-world data. Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi. PMID 30316726 DOI: 10.1016/J.Jmii.2018.09.005  0.333
2018 Yang HC, Kao JH. Quantification of HBV core antibodies may help revisit infectious occult hepatitis B virus. Gut. PMID 30301771 DOI: 10.1136/Gutjnl-2018-317385  0.333
2018 Kao JH. Hepatitis B: From control to cure. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 30201191 DOI: 10.1016/j.jfma.2018.08.020  0.327
2018 Lin CL, Kao JH. Review article: the prevention of hepatitis B-related hepatocellular carcinoma. Alimentary Pharmacology & Therapeutics. PMID 29722445 DOI: 10.1111/apt.14683  0.337
2018 Reau N, Kwo PY, Rhee S, Brown RS, Agarwal K, Angus P, Gane E, Kao JH, Mantry PS, Mutimer D, Reddy KR, Tran TT, Hu YB, Gulati A, Krishnan P, et al. Glecaprevir/Pibrentasvir Treatment in Liver or Kidney Transplant Patients With Hepatitis C Virus Infection. Hepatology (Baltimore, Md.). PMID 29672891 DOI: 10.1002/Hep.30046  0.335
2018 Lin CL, Kao JH. Prevention of mother-to-child transmission: the key of hepatitis B virus elimination. Hepatology International. PMID 29619622 DOI: 10.1007/s12072-018-9863-0  0.309
2018 Hsu CW, Su WW, Lee CM, Peng CY, Chuang WL, Kao JH, Chu HC, Huang YH, Chien RN, Liaw YF. Phase IV randomized clinical study: Peginterferon alfa-2a with adefovir or entecavir pre-therapy for HBeAg-positive chronic hepatitis B. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 29456079 DOI: 10.1016/j.jfma.2017.12.007  0.348
2018 Rivino L, Le Bert N, Gill US, Kunasegaran K, Cheng Y, Tan DZ, Becht E, Hansi NK, Foster GR, Su TH, Tseng TC, Lim SG, Kao JH, Newell EW, Kennedy PT, et al. Hepatitis B virus-specific T cells associate with viral control upon nucleos(t)ide-analogue therapy discontinuation. The Journal of Clinical Investigation. PMID 29309050 DOI: 10.1172/JCI92812  0.347
2018 Yeo Y, Ho H, Yang H, Tseng T, Kwak M, Park Y, Fung Y, Ferret M, Rodríguez M, Preda C, Ungtrakul T, Charatcharoenwitthaya P, Li X, Huan Le M, Wei B, ... ... Kao J, et al. Real-world rates of hepatitis B surface antigen seroclearance in patients with chronic hepatitis B: a systematic review, conventional aggregated data meta-analysis and individual patient data meta-analysis Journal of Hepatology. 68: S478-S479. DOI: 10.1016/S0168-8278(18)31207-8  0.328
2018 Liu C, Yang S, Yang S, Sun H, Liu C, Liu W, Su T, Yang H, Hong C, Tseng T, Chen P, Chen D, Hung C, Kao J. Generic sofosbuvir-based interferon-free direct acting antiviral agents for patients with chronic hepatitis C virus infection: a real-world multicenter observational study Journal of Hepatology. 68: S266. DOI: 10.1016/S0168-8278(18)30745-1  0.369
2018 Yeo YH, Ho HJ, Yang H, Tseng T, Kwak M, Park YM, Fung JY, Buti M, Rodriguez M, Treeprasertsuk S, Preda CM, Ungtrakul T, Charatcharoenwitthaya P, Li X, Le MH, ... ... Kao J, et al. Sa1483 - Real-World Rates of Hepatitis B Surface Antigen (HBSAG) Seroclearance in Patients with Chronic Hepatitis B (CHB): A Systematic Review, Conventional Aggregated Data Meta-Analysis (ADMA) and Individual Patient Data Meta-Analysis (IPDMA) Gastroenterology. 154: S-1128. DOI: 10.1016/S0016-5085(18)33750-8  0.337
2017 Tseng CH, Hsu YC, Chang CY, Tseng TC, Wu MS, Lin JT, Kao JH. Quantification of serum hepatitis B core antibody to predict off-entecavir relapse in patients with chronic hepatitis B. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 29249417 DOI: 10.1016/j.jfma.2017.11.012  0.342
2017 Chien NH, Huang YT, Wu CY, Chang CY, Wu MS, Kao JH, Mo LR, Tai CM, Lin CW, Yang TH, Lin JT, Hsu YC. Time-varying serum gradient of hepatitis B surface antigen predicts risk of relapses after off-NA therapy. Bmc Gastroenterology. 17: 154. PMID 29221441 DOI: 10.1186/s12876-017-0697-3  0.328
2017 Su TH, Kao JH. Unmet Needs in Clinical and Basic Hepatitis B Virus Research. The Journal of Infectious Diseases. 216: S750-S756. PMID 29156048 DOI: 10.1093/infdis/jix382  0.396
2017 Liu CJ, Kao JH. NOhep: Toward Global Control of Hepatitis B Virus Infection-An Introduction. The Journal of Infectious Diseases. 216: S749. PMID 29156045 DOI: 10.1093/infdis/jix313  0.346
2017 Liu CH, Chen YS, Wang SS, Liu CJ, Su TH, Yang HC, Hong CM, Chen PJ, Chen DS, Kao JH. Sofosbuvir-based interferon-free direct acting antiviral regimens for heart transplant recipients with chronic hepatitis C virus infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 29020359 DOI: 10.1093/Cid/Cix787  0.339
2017 Tseng TC, Liu CJ, Su TH, Yang WT, Chen CL, Yang HC, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Fibrosis-4 Index Helps Identify HBV Carriers With the Lowest Risk of Hepatocellular Carcinoma. The American Journal of Gastroenterology. PMID 28853728 DOI: 10.1038/Ajg.2017.254  0.327
2017 Lin CL, Kao JH. Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants. Best Practice & Research. Clinical Gastroenterology. 31: 249-255. PMID 28774406 DOI: 10.1016/j.bpg.2017.04.010  0.424
2017 Liu CH, Liu CJ, Su TH, Yang HC, Hong CM, Tseng TC, Chen PJ, Chen DS, Kao JH. Real-world effectiveness and safety of paritaprevir/ritonavir, ombitasvir, and dasabuvir with or without ribavirin for patients with chronic hepatitis C virus genotype 1b infection in Taiwan. Journal of Gastroenterology and Hepatology. PMID 28762541 DOI: 10.1111/Jgh.13912  0.412
2017 Hsieh MH, Yeh ML, Su TH, Liu TW, Huang CF, Huang CI, Wang SC, Huang JF, Dai CY, Kao JH, Chuang WL, Chen PJ, Liu CJ, Yu ML. Boceprevir-based triple therapy to rescue HCV genotype 1/HBV dually infected patients refractory to peginterferon plus ribavirin combination therapy in Taiwan. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 28694000 DOI: 10.1016/j.jfma.2017.06.007  0.396
2017 Lee MH, Huang CF, Lai HC, Lin CY, Dai CY, Liu CJ, Wang JH, Huang JF, Su WP, Yang HC, Kee KM, Yeh ML, Chuang PH, Hsu SJ, Huang CI, ... Kao JT, ... ... Kao JH, et al. Clinical Efficacy and Post-Treatment Seromarkers Associated with the Risk of Hepatocellular Carcinoma among Chronic Hepatitis C Patients. Scientific Reports. 7: 3718. PMID 28623331 DOI: 10.1038/S41598-017-02313-Y  0.315
2017 Wang CC, Kao JH. Letter: the influence of direct acting agents for hepatitis C, on hepatitis B reactivation. Alimentary Pharmacology & Therapeutics. 46: 208. PMID 28621067 DOI: 10.1111/apt.14116  0.377
2017 Liu CH, Liu CJ, Hong CM, Su TH, Yang HC, Chen KM, Huang YP, Yeh YM, Tien HL, Liu YC, Kao JH, Chen DS, Chen PJ. A noninvasive diagnosis of hepatic fibrosis by BioFibroScore® in chronic hepatitis C patients. Journal of Gastroenterology and Hepatology. PMID 28548299 DOI: 10.1111/Jgh.13834  0.424
2017 Wang CC, Kao JH. Hepatitis B virus infection and decreased risk of nonalcoholic fatty liver disease: A cohort study. Hepatology (Baltimore, Md.). PMID 28480982 DOI: 10.1002/hep.29252  0.348
2017 Liu CH, Liu CJ, Su TH, Fang YJ, Yang HC, Chen PJ, Chen DS, Kao JH. Hepatitis B Virus Reactivation in Patients Receiving Interferon-Free Direct-Acting Antiviral Agents for Chronic Hepatitis C Virus Infection. Open Forum Infectious Diseases. 4: ofx028. PMID 28480296 DOI: 10.1093/Ofid/Ofx028  0.427
2017 Tseng TC, Kao JH. Elimination of Hepatitis B: Is It a Mission Possible? Bmc Medicine. 15: 53. PMID 28292309 DOI: 10.1186/s12916-017-0820-x  0.4
2017 Hsu YC, Mo LR, Chang CY, Wu MS, Yang TH, Kao JH, Chen CC, Tseng CH, Tai CM, Lin CW, Wu CY, Lin JT. Serum viral load at the virological relapse predicts subsequent clinical flares in chronic hepatitis B patients off entecavir therapy. Journal of Gastroenterology and Hepatology. PMID 28122151 DOI: 10.1111/jgh.13728  0.37
2017 Nien HC, Hsu SJ, Su TH, Yang PJ, Sheu JC, Wang JT, Chow LP, Chen CL, Kao JH, Yang WS. High Serum Lipopolysaccharide-Binding Protein Level in Chronic Hepatitis C Viral Infection Is Reduced by Anti-Viral Treatments. Plos One. 12: e0170028. PMID 28107471 DOI: 10.1371/journal.pone.0170028  0.354
2017 Liu CH, Chen YS, Wang SS, Kao JH. Treatment of de novo hepatitis C virus-related fibrosing cholestatic hepatitis after orthotopic heart transplantation by ledipasvir and sofosbuvir. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 28089092 DOI: 10.1016/j.jfma.2016.12.005  0.327
2017 Su TH, Kao JH. Response to Four-year entecavir therapy reduces hepatocellular carcinoma, cirrhotic events and mortality in chronic hepatitis B patients. Liver International : Official Journal of the International Association For the Study of the Liver. 37: 310-311. PMID 28070982 DOI: 10.1111/liv.13315  0.331
2017 Lin CL, Kao JH. Hepatitis B reactivation in patients receiving immunosuppressive therapy: a hidden menace. Hepatology International. PMID 28058576 DOI: 10.1007/s12072-016-9782-x  0.341
2017 Zeuzem S, Han K, Ahn S, Lim Y, Kao J, Chuang W, Omata M, Abramov F, Crans G, Llewellyn J, Natha M, De-Oertel S, Brainard D, Foster G, Gane E, et al. Sofosbuvir-based all-oral regimens for patients with chronic hepatitis C genotype 2 infection: integrated analysis of eleven clinical studies Journal of Hepatology. 66: S738-S739. DOI: 10.1016/S0168-8278(17)31968-2  0.345
2017 Wei L, Wang G, Luo Y, Chu C, Paik S, Hou J, Cheng J, Xie Q, Duan Z, Kao J, Fu B, Fredrick L, Mobashery N, Heo J. Efficacy and safety of ombitasvir/paritaprevir/ritonavir and dasabuvir with ribavirin in Asian patients with genotype 1b chronic hepatitis C virus infection and compensated cirrhosis: ONYX-II post-treatment week 24 results Journal of Hepatology. 66: S532. DOI: 10.1016/S0168-8278(17)31466-6  0.392
2017 Liu C, Liu C, Su T, Yang H, Kao J, Chen D, Chen P. Noninvasive diagnosis of hepatic fibrosis by biofibroscore ® in patients with chronic hepatitis C virus infection Journal of Hepatology. 66: S233-S234. DOI: 10.1016/S0168-8278(17)30770-5  0.413
2017 Ho SB, Han KH, Ahn SH, Lim Y, Kao J, Chuang WL, Omata M, Moon S, Crans G, Llewellyn J, Natha M, De-Oertel S, Brainard D, Foster GR, Gane E, et al. Sofosbuvir-Based all-Oral Regimens for Patients with Chronic Hepatitis C Genotype 2 Infection: Integrated Analysis of Eleven Clinical Studies Gastroenterology. 152: S1095. DOI: 10.1016/S0016-5085(17)33689-2  0.345
2016 Lin CL, Kao JH. New perspectives of biomarkers for the management of chronic hepatitis B. Clinical and Molecular Hepatology. 22: 423-431. PMID 28081591 DOI: 10.3350/cmh.2016.0069  0.418
2016 Chen HY, Su TH, Tseng TC, Yang WT, Chen TC, Chen PJ, Chen DS, Kao JH, Liu CJ. Impact of occult hepatitis B on the clinical outcomes of patients with chronic hepatitis C virus infection: A 10-year follow-up. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 28012674 DOI: 10.1016/j.jfma.2016.11.002  0.463
2016 Kao JH, Ahn SH, Chien RN, Cho M, Chuang WL, Jeong SH, Liu CH, Paik SW. Urgency to treat patients with chronic hepatitis C in Asia. Journal of Gastroenterology and Hepatology. PMID 28005275 DOI: 10.1111/jgh.13709  0.371
2016 Wei L, Kao JH. Benefits of long-term therapy with nucleos(t)ide analogues in treatment-naïve patients with chronic hepatitis B. Current Medical Research and Opinion. 1-32. PMID 27882776 DOI: 10.1080/03007995.2016.1264932  0.331
2016 Mah YH, Liu CH, Chen CL, Tseng TC, Liu CJ, Chen PJ, Chen DS, Kao JH. Prevalence and clinical implications of IL28B genotypes in Taiwanese patients with chronic hepatitis C. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 27751759 DOI: 10.1016/j.jfma.2016.07.013  0.369
2016 Su TH, Hu TH, Chen CY, Huang YH, Chuang WL, Lin CC, Wang CC, Su WW, Chen MY, Peng CY, Chien RN, Huang YW, Wang HY, Lin CL, Yang SS, ... ... Kao JH, et al. Four-Year Entecavir Therapy Reduces Hepatocellular Carcinoma, Cirrhotic Events, and Mortality in Chronic Hepatitis B Patients. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 27634134 DOI: 10.1111/liv.13253  0.456
2016 Wu HL, Hsiao TH, Chen PJ, Wong SH, Kao JH, Chen DS, Lu JY, Lu TP, Chen Y, Chuang EY, Tu HC, Liu CJ. Liver Gene Expression Profiles Correlate with Virus Infection and Response to Interferon Therapy in Chronic Hepatitis B Patients. Scientific Reports. 6: 31349. PMID 27546197 DOI: 10.1038/srep31349  0.352
2016 Kao JH, Asselah T, Dou XG, Hamed K. Telbivudine therapy for chronic hepatitis B: a journey to identify super-responders and to optimize treatment using the roadmap model. Journal of Gastroenterology and Hepatology. PMID 27515408 DOI: 10.1111/jgh.13512  0.356
2016 Sulkowski MS, Chuang WL, Kao JH, Yang JC, Gao B, Brainard DM, Han KH, Gane E. No Evidence of Reactivation of Hepatitis B Virus Among Patients Treated with Ledipasvir-Sofosbuvir for Hepatitis C Virus Infection. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 27486112 DOI: 10.1093/cid/ciw507  0.433
2016 Flisiak R, Kawazoe S, Znoyko O, Assy N, Gadano A, Kao JH, Lee KS, Zwirtes R, Portsmouth S, Dong Y, Xu D, Kumada H, Srinivasan S. Peginterferon Lambda-1a/Ribavirin with Daclatasvir or Peginterferon Alfa-2a/Ribavirin with Telaprevir for Chronic Hepatitis C Genotype 1b. Journal of Interferon & Cytokine Research : the Official Journal of the International Society For Interferon and Cytokine Research. PMID 27327078 DOI: 10.1089/jir.2015.0173  0.362
2016 Lin CL, Kao JH. Review article: novel therapies for hepatitis B virus cure - advances and perspectives. Alimentary Pharmacology & Therapeutics. PMID 27302653 DOI: 10.1111/apt.13694  0.404
2016 Omata M, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Al-Mahtab M, McCaughan GW, ... ... Kao JH, et al. APASL consensus statements and recommendations for hepatitis C prevention, epidemiology, and laboratory testing. Hepatology International. PMID 27229718 DOI: 10.1007/s12072-016-9736-3  0.321
2016 Omata M, Kanda T, Wei L, Yu ML, Chuang WL, Ibrahim A, Lesmana CR, Sollano J, Kumar M, Jindal A, Sharma BC, Hamid SS, Dokmeci AK, Mamun-Al-Mahtab, McCaughan GW, ... ... Kao JH, et al. APASL consensus statements and recommendation on treatment of hepatitis C. Hepatology International. PMID 27130427 DOI: 10.1007/s12072-016-9717-6  0.331
2016 Jensen DM, Asselah T, Dieterich D, Foster GR, Sulkowski MS, Zeuzem S, Mantry P, Yoshida EM, Moreno C, Ouzan D, Wright M, Morano LE, Buynak R, Bourlière M, Hassanein T, ... ... Kao JH, et al.  Faldaprevir, pegylated interferon, and ribavirin for treatment-naïve HCV genotype-1: pooled analysis of two phase 3 trials. Annals of Hepatology. 15: 333-349. PMID 27049487 DOI: 10.5604/16652681.1198803  0.3
2016 Wang CC, Tseng KC, Hsieh TY, Tseng TC, Lin HH, Kao JH. Assessing the Durability of Entecavir-Treated Hepatitis B Using Quantitative HBsAg. The American Journal of Gastroenterology. PMID 27045923 DOI: 10.1038/ajg.2016.109  0.37
2016 Kao JH, Lee YJ, Heo J, Ahn SH, Lim YS, Peng CY, Chang TT, Torbeyns A, Hughes E, Bhore R, Noviello S. All-oral daclatasvir plus asunaprevir for chronic HCV genotype 1b infection: a sub-analysis in Asian patients from the HALLMARK DUAL study. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 27009831 DOI: 10.1111/liv.13128  0.339
2016 Kao JH, Tung SY, Lee Y, Thongsawat S, Tanwandee T, Sheen IS, Wu JJ, Li H, Brennan BJ, Zhou J, Le Pogam S, Najera I, Thommes JA, Hill G. Ritonavir-boosted danoprevir plus peginterferon alfa-2a and ribavirin in Asian chronic hepatitis C patients with or without cirrhosis. Journal of Gastroenterology and Hepatology. PMID 26992248 DOI: 10.1111/jgh.13374  0.34
2016 Yang WT, Wu LW, Tseng TC, Chen CL, Yang HC, Su TH, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Liu CJ, Kao JH. Hepatitis B Surface Antigen Loss and Hepatocellular Carcinoma Development in Patients With Dual Hepatitis B and C Infection. Medicine. 95: e2995. PMID 26962809 DOI: 10.1097/Md.0000000000002995  0.415
2016 Chuang WL, Chien RN, Peng CY, Chang TT, Lo GH, Sheen IS, Wang HY, Chen JJ, Yang JC, Knox SJ, Gao B, Garrison KL, Mo H, Pang PS, Hsu YC, ... ... Kao JH, et al. Ledipasvir/sofosbuvir fixed-dose combination tablet in Taiwanese patients with chronic genotype 1 hepatitis C virus. Journal of Gastroenterology and Hepatology. PMID 26841930 DOI: 10.1111/Jgh.13305  0.341
2016 Kao JH, Chien RN, Chang TT, Peng CY, Hu TH, Lo GH, Wang HY, Chen JJ, Yang JC, Knox SJ, Han L, Mo H, Mathias A, Brainard DM, Sheen IS, et al. A phase 3b study of sofosbuvir plus ribavirin in Taiwanese patients with chronic genotype 2 hepatitis C virus infection. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 26835876 DOI: 10.1111/liv.13082  0.399
2016 Hsu CS, Kao JH. Management of hepatitis C patients with decompensated liver disease. Expert Review of Gastroenterology & Hepatology. PMID 26782619 DOI: 10.1586/17474124.2016.1143775  0.384
2016 Yang HC, Kao JH. Looking into the crystal ball: biomarkers for outcomes of HBV infection. Hepatology International. PMID 26732689 DOI: 10.1007/S12072-015-9698-X  0.35
2016 Lin CL, Yang HC, Kao JH. Hepatitis B virus: new therapeutic perspectives. Liver International : Official Journal of the International Association For the Study of the Liver. 36: 85-92. PMID 26725903 DOI: 10.1111/Liv.13003  0.38
2016 Liu C, Chen C, Liu C, Su T, Yang H, Chen P, Chen D, Kao J. Long-Term Assessment of Renal Function in Patients following Antiviral Therapy for Chronic Hepatitis C Virus Infection Journal of Hepatology. 64: S610. DOI: 10.1016/S0168-8278(16)01129-6  0.315
2015 Kao JH, Jensen DM, Manns MP, Jacobson I, Kumada H, Toyota J, Heo J, Yoffe B, Sievert W, Bessone F, Peng CY, Roberts SK, Lee YJ, Bhore R, Mendez P, et al. Daclatasvir Plus Asunaprevir for HCV Genotype 1b Infection in Patients With or Without Compensated Cirrhosis: A Pooled Analysis. Liver International : Official Journal of the International Association For the Study of the Liver. PMID 26683763 DOI: 10.1111/liv.13049  0.342
2015 Su TH, Liu CJ, Tseng TC, Chou SW, Liu CH, Yang HC, Wu SJ, Chen PJ, Chen DS, Chen CL, Kao JH. Hepatitis C virus infection increases the risk of lymphoid-neoplasms: A population-based cohort study. Hepatology (Baltimore, Md.). PMID 26662347 DOI: 10.1002/Hep.28387  0.319
2015 Kao JH. Hepatitis B vaccination and prevention of hepatocellular carcinoma. Best Practice & Research. Clinical Gastroenterology. 29: 907-917. PMID 26651252 DOI: 10.1016/j.bpg.2015.09.011  0.348
2015 Yang HI, Tseng TC, Liu J, Lee MH, Liu CJ, Su TH, Batrla-Utermann R, Chan HL, Kao JH, Chen CJ. 'Incorporating Serum Level of Hepatitis B Surface Antigen or Omitting Level of HBV DNA Does not Affect Calculation of Risk for Hepatocellular Carcinoma in Patients Without Cirrhosis'. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. PMID 26598229 DOI: 10.1016/j.cgh.2015.10.033  0.369
2015 Sarin SK, Kumar M, Lau GK, Abbas Z, Chan HL, Chen CJ, Chen DS, Chen HL, Chen PJ, Chien RN, Dokmeci AK, Gane E, Hou JL, Jafri W, Jia J, ... ... Kao JH, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatology International. PMID 26563120 DOI: 10.1007/S12072-015-9675-4  0.333
2015 Yang SS, Kao JH. Daclatasvir-containing all-oral regimens for the treatment of hepatitis C virus infection. Hepatology International. PMID 26542068 DOI: 10.1007/s12072-015-9668-3  0.38
2015 Tseng KC, Tseng CW, Hsieh TY, Peng CY, Lin CL, Su TH, Tseng TC, Lin HH, Wang CC, Kao JH. Efficacy of entecavir therapy for HBeAg-positive chronic hepatitis B patients with prior exposure to interferon or nucleos(t)ide analogues. Hepatology Research : the Official Journal of the Japan Society of Hepatology. PMID 26422680 DOI: 10.1111/hepr.12600  0.33
2015 Wang CC, Lin CL, Hsieh TY, Tseng KC, Peng CY, Su TH, Yang SS, Hsu YC, Chen TM, Kao JH. Efficacy and resistance to telbivudine treatment in chronic hepatitis B patients with favorable predictors: a multicenter study in Taiwan. Hepatology International. PMID 26399763 DOI: 10.1007/s12072-015-9662-9  0.344
2015 Wang CC, Liu CH, Lin CL, Wang PC, Tseng TC, Lin HH, Kao JH. Fibrosis index based on four factors better predicts advanced fibrosis or cirrhosis than aspartate aminotransferase/platelet ratio index in chronic hepatitis C patients. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 26279173 DOI: 10.1016/j.jfma.2015.07.004  0.35
2015 Kao JH. Hepatitis C virus infection in Taiwan: Past, present, and future. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 26228687 DOI: 10.1016/j.jfma.2015.06.012  0.337
2015 Liu CJ, Chen PJ, Chen DS, Tseng TC, Kao JH. Perspectives on dual hepatitis B and C infection in Taiwan. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 26188762 DOI: 10.1016/j.jfma.2015.06.005  0.437
2015 Lin CL, Kao JH. Perspectives and control of hepatitis B virus infection in Taiwan. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 114: 901-9. PMID 26184565 DOI: 10.1016/j.jfma.2015.06.003  0.386
2015 Huang YW, Chayama K, Kao JH, Yang SS. Detectability and clinical significance of serum hepatitis B virus ribonucleic acid. Hepatobiliary Surgery and Nutrition. 4: 197-202. PMID 26151059 DOI: 10.3978/j.issn.2304-3881.2014.11.08  0.326
2015 Bennett H, Waser N, Johnston K, Kao JH, Lim YS, Duan ZP, Lee YJ, Wei L, Chen CJ, Sievert W, Yuan Y, Li H. A review of the burden of hepatitis C virus infection in China, Japan, South Korea and Taiwan. Hepatology International. 9: 378-90. PMID 26071238 DOI: 10.1007/s12072-015-9629-x  0.342
2015 Lin CL, Kao JH. Hepatitis B virus genotypes and variants. Cold Spring Harbor Perspectives in Medicine. 5: a021436. PMID 25934462 DOI: 10.1101/cshperspect.a021436  0.404
2015 Lin CL, Kao JH. Can noninvasive biomarkers replace liver biopsy for chronic hepatitis B? Hepatology (Baltimore, Md.). PMID 25914237 DOI: 10.1002/hep.27865  0.35
2015 Chen CL, Yang JY, Lin SF, Sun CA, Bai CH, You SL, Chen CJ, Kao JH, Chen PJ, Chen DS. Slow decline of hepatitis B burden in general population: Results from a population-based survey and longitudinal follow-up study in Taiwan. Journal of Hepatology. PMID 25795588 DOI: 10.1016/j.jhep.2015.03.013  0.309
2015 Cheng HR, Kao JH, Wu HL, Tseng TC, Liu CH, Yang HC, Su TH, Chen PJ, Chen DS, Liu CJ. Clinical significance of circulating miR-122 in patients with dual chronic hepatitis B and C virus infection. Hepatology International. 9: 35-42. PMID 25788377 DOI: 10.1007/S12072-014-9591-Z  0.341
2015 Hsu CS, Liu WL, Chao YC, Lin HH, Tseng TC, Wang CC, Chen DS, Kao JH. Adipocytokines and liver fibrosis stages in patients with chronic hepatitis B virus infection. Hepatology International. 9: 231-42. PMID 25788201 DOI: 10.1007/s12072-015-9616-2  0.393
2015 Liu CH, Liang CC, Liu CJ, Lin CL, Su TH, Yang HC, Chen PJ, Chen DS, Kao JH. Comparison of Abbott RealTime HCV Genotype II with Versant line probe assay 2.0 for hepatitis C virus genotyping. Journal of Clinical Microbiology. 53: 1754-7. PMID 25740780 DOI: 10.1128/Jcm.03548-14  0.333
2015 Zeisel MB, Lucifora J, Mason WS, Sureau C, Beck J, Levrero M, Kann M, Knolle PA, Benkirane M, Durantel D, Michel ML, Autran B, Cosset FL, Strick-Marchand H, Trépo C, ... Kao JH, et al. Towards an HBV cure: state-of-the-art and unresolved questions-report of the ANRS workshop on HBV cure. Gut. 64: 1314-26. PMID 25670809 DOI: 10.1136/gutjnl-2014-308943  0.361
2015 Lin CL, Tseng TC, Kao JH. What can we learn from hepatitis B virus clinical cohorts? Liver International : Official Journal of the International Association For the Study of the Liver. 35: 91-9. PMID 25529093 DOI: 10.1111/liv.12716  0.403
2015 Liu J, Tseng TC, Yang HI, Lee MH, Batrla-Utermann R, Jen CL, Lu SN, Wang LY, You SL, Chen PJ, Chen CJ, Kao JH. Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System. The Journal of Infectious Diseases. 211: 1566-73. PMID 25430663 DOI: 10.1093/infdis/jiu659  0.408
2015 Tseng TC, Kao JH. Treating Immune-tolerant Hepatitis B. Journal of Viral Hepatitis. 22: 77-84. PMID 25424771 DOI: 10.1111/jvh.12370  0.327
2015 Liang CC, Liu CH, Chung CS, Lin CK, Su TH, Yang HC, Liu CJ, Chen PJ, Chen DS, Kao JH. Advanced hepatic fibrosis and steatosis are associated with persistent alanine aminotransferase elevation in chronic hepatitis C patients negative for hepatitis C virus RNA during pegylated interferon plus ribavirin therapy. The Journal of Infectious Diseases. 211: 1429-36. PMID 25387585 DOI: 10.1093/Infdis/Jiu630  0.409
2015 Su TH, Kao JH. Improving clinical outcomes of chronic hepatitis B virus infection. Expert Review of Gastroenterology & Hepatology. 9: 141-54. PMID 25241970 DOI: 10.1586/17474124.2015.960398  0.413
2015 Yang SS, Kao JH. Asunaprevir-containing regimens for the treatment of hepatitis C virus infection. Expert Review of Gastroenterology & Hepatology. 9: 9-20. PMID 25174254 DOI: 10.1586/17474124.2014.953930  0.367
2015 Wang CC, Tseng TC, Kao JH. Hepatitis B virus infection and metabolic syndrome: fact or fiction? Journal of Gastroenterology and Hepatology. 30: 14-20. PMID 25092429 DOI: 10.1111/jgh.12700  0.361
2015 Liu CJ, Chen TC, Chen PJ, Wang HY, Tseng TC, Cheng HR, Liu CH, Chen DS, Kao JH. Micro-evolution of the hepatitis B virus genome in hepatitis B e-antigen-positive carriers: comparison of genotypes B and C at various immune stages. Journal of Gastroenterology and Hepatology. 30: 172-7. PMID 25040688 DOI: 10.1111/jgh.12654  0.393
2015 Tseng TC, Liu CJ, Yang HC, Chen CL, Yang WT, Tsai CS, Kuo SF, Verbree FC, Su TH, Wang CC, Liu CH, Chen PJ, Chen DS, Kao JH. Higher proportion of viral basal core promoter mutant increases the risk of liver cirrhosis in hepatitis B carriers. Gut. 64: 292-302. PMID 24763132 DOI: 10.1136/Gutjnl-2014-306977  0.365
2015 Liu CH, Liu CJ, Huang CF, Lin JW, Dai CY, Liang CC, Huang JF, Hung PH, Tsai HB, Tsai MK, Lee CY, Chen SI, Yang SS, Su TH, Yang HC, ... ... Kao JH, et al. Peginterferon alfa-2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 2 receiving haemodialysis: a randomised trial. Gut. 64: 303-11. PMID 24747867 DOI: 10.1136/Gutjnl-2014-307080  0.355
2015 Peng CY, Hsieh TC, Hsieh TY, Tseng KC, Lin CL, Su TH, Tseng TC, Lin HH, Wang CC, Kao JH. HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 114: 308-13. PMID 24315616 DOI: 10.1016/j.jfma.2013.10.023  0.371
2014 Yang HC, Kao JH. Persistence of hepatitis B virus covalently closed circular DNA in hepatocytes: molecular mechanisms and clinical significance. Emerging Microbes & Infections. 3: e64. PMID 26038757 DOI: 10.1038/Emi.2014.64  0.413
2014 Lin CL, Liu CH, Wang CC, Liang CC, Su TH, Liu CJ, Kao JH. Serum Biomarkers Predictive of Significant Fibrosis and Cirrhosis in Chronic Hepatitis B. Journal of Clinical Gastroenterology. PMID 25319739 DOI: 10.1097/MCG.0000000000000250  0.38
2014 Lin SR, Yang HC, Kuo YT, Liu CJ, Yang TY, Sung KC, Lin YY, Wang HY, Wang CC, Shen YC, Wu FY, Kao JH, Chen DS, Chen PJ. The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo. Molecular Therapy. Nucleic Acids. 3: e186. PMID 25137139 DOI: 10.1038/Mtna.2014.38  0.354
2014 Manns M, Pol S, Jacobson IM, Marcellin P, Gordon SC, Peng CY, Chang TT, Everson GT, Heo J, Gerken G, Yoffe B, Towner WJ, Bourliere M, Metivier S, Chu CJ, ... ... Kao JH, et al. All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study. Lancet (London, England). 384: 1597-605. PMID 25078304 DOI: 10.1016/S0140-6736(14)61059-X  0.407
2014 Hsu CS, Hsu SJ, Lin HH, Tseng TC, Wang CC, Chen DS, Kao JH. A pilot study of add-on oral hypoglycemic agents in treatment-naïve genotype-1 chronic hepatitis C patients receiving peginterferon alfa-2b plus ribavirin. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 113: 716-21. PMID 24974131 DOI: 10.1016/j.jfma.2014.05.007  0.339
2014 Su TH, Kao JH, Liu CJ. Molecular mechanism and treatment of viral hepatitis-related liver fibrosis. International Journal of Molecular Sciences. 15: 10578-604. PMID 24927147 DOI: 10.3390/ijms150610578  0.347
2014 Chen CL, Yang WS, Yang HI, Chen CF, You SL, Wang LY, Lu SN, Liu CJ, Kao JH, Chen PJ, Chen DS, Chen CJ. Plasma adipokines and risk of hepatocellular carcinoma in chronic hepatitis B virus-infected carriers: a prospective study in taiwan. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1659-71. PMID 24895413 DOI: 10.1158/1055-9965.EPI-14-0161  0.315
2014 Liu CH, Kao JH. Nanomedicines in the treatment of hepatitis C virus infection in Asian patients: optimizing use of peginterferon alfa. International Journal of Nanomedicine. 9: 2051-67. PMID 24812506 DOI: 10.2147/IJN.S41822  0.355
2014 Tseng TC, Kao JH, Chen DS. Peginterferon α in the treatment of chronic hepatitis B. Expert Opinion On Biological Therapy. 14: 995-1006. PMID 24738850 DOI: 10.1517/14712598.2014.907784  0.346
2014 Liu CH, Kao JH. Triple therapy for hepatitis C virus infection in patients receiving hemodialysis. Annals of Internal Medicine. 160: 581-2. PMID 24733208 DOI: 10.7326/L14-5008-4  0.35
2014 Wu HL, Kao JH, Chen TC, Wu WH, Liu CH, Su TH, Yang HC, Chen DS, Chen PJ, Liu CJ. Serum cytokine/chemokine profiles in acute exacerbation of chronic hepatitis B: clinical and mechanistic implications. Journal of Gastroenterology and Hepatology. 29: 1629-36. PMID 24730549 DOI: 10.1111/Jgh.12606  0.368
2014 Tseng TC, Liu CJ, Yang WT, Chen CL, Yang HC, Su TH, Wang CC, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters. Journal of Gastroenterology and Hepatology. 29: 1242-9. PMID 24384028 DOI: 10.1111/Jgh.12502  0.365
2014 Kao JH. HBeAg-positive chronic hepatitis B: why do I treat my patients with pegylated interferon? Liver International : Official Journal of the International Association For the Study of the Liver. 34: 112-9. PMID 24373087 DOI: 10.1111/liv.12400  0.39
2014 Chien RN, Peng CY, Kao JH, Hu TH, Lin CC, Hu CT, Chen CY, Hsieh TY, Lin HC, Chuang WL. Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology. 29: 185-92. PMID 24354995 DOI: 10.1111/jgh.12416  0.373
2014 Cheng HR, Kao JH, Wu HL, Chen TC, Tseng TC, Liu CH, Su TH, Chen PJ, Chen DS, Liu CJ. Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously. Liver International : Official Journal of the International Association For the Study of the Liver. 34: e71-9. PMID 24119014 DOI: 10.1111/liv.12324  0.417
2014 Wang CC, Tseng TC, Wang PC, Lin HH, Kao JH. Baseline hepatitis B surface antigen quantitation can predict virologic response in entecavir-treated chronic hepatitis B patients. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 113: 786-93. PMID 23911291 DOI: 10.1016/j.jfma.2013.06.003  0.395
2014 Chen MY, Liu CH, Chen TC, Su TH, Chen PJ, Chen DS, Kao JH, Liu CJ. Value of interleukin-28B genetic polymorphism on retreatment outcomes of chronic hepatitis C genotype 1 relapsers by peginterferon alfa plus ribavirin. Journal of Gastroenterology and Hepatology. 29: 102-9. PMID 23829453 DOI: 10.1111/jgh.12329  0.359
2014 Su TH, Liu CJ, Yang HC, Jeng YM, Cheng HR, Liu CH, Tseng TC, Ling TY, Chen PJ, Chen DS, Kao JH. Clinical significance and evolution of hepatic HBsAg expression in HBeAg-positive patients receiving interferon therapy. Journal of Gastroenterology. 49: 356-62. PMID 23736797 DOI: 10.1007/S00535-013-0840-Z  0.396
2014 Kao JH. Risk stratification of HBV infection in asia-pacific region Clinical and Molecular Hepatology. 20: 223-227. DOI: 10.3350/cmh.20U.20.3.227  0.359
2014 Huang Y, Wang T, Hsu C, Chen D, Hu J, Kao J, Yang S. P642 LOWER RISK OF CIRRHOSIS AND HEPATOCELLULAR CARCINOMA IN NON-DIABETIC CHRONIC HEPATITIS B PATIENTS WITH NEW ONSET HYPERLIPIDEMIA: A NATIONWIDE COHORT STUDY Journal of Hepatology. 60: S282. DOI: 10.1016/S0168-8278(14)60804-7  0.308
2014 Liu C, Wu L, Tseng T, Yang W, Su T, Yang H, Liu C, Kao J, Chen D, Chen P. P639 SPONTANEOUS SEROCLEARANCE OF HBsAg IN HEPATITIS B VIRUS/HEPATITIS C VIRUS DUALLY INFECTED PATIENTS: A 10-YEAR FOLLOW-UP Journal of Hepatology. 60: S281. DOI: 10.1016/S0168-8278(14)60801-1  0.397
2013 Hsu CS, Hsu SJ, Chen HC, Liu CH, Jeng J, Liu CJ, Chen PJ, Chen DS, Kao JH. Association of IL28B genotypes with metabolic profiles and viral clearance rate in chronic hepatitis C patients. Hepatology International. 7: 171-9. PMID 26201631 DOI: 10.1007/s12072-012-9390-3  0.343
2013 Huang YW, Wang TC, Lin SC, Chang HY, Chen DS, Hu JT, Yang SS, Kao JH. Increased risk of cirrhosis and its decompensation in chronic hepatitis B patients with newly diagnosed diabetes: a nationwide cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 57: 1695-702. PMID 24051864 DOI: 10.1093/cid/cit603  0.326
2013 Hsu CS, Huang CJ, Kao JH, Lin HH, Chao YC, Fan YC, Tsai PS. Interferon-based therapy decreases risks of hepatocellular carcinoma and complications of cirrhosis in chronic hepatitis C patients. Plos One. 8: e70458. PMID 23894660 DOI: 10.1371/journal.pone.0070458  0.385
2013 Hsu CS, Kao JH, Chao YC, Lin HH, Fan YC, Huang CJ, Tsai PS. Interferon-based therapy reduces risk of stroke in chronic hepatitis C patients: a population-based cohort study in Taiwan. Alimentary Pharmacology & Therapeutics. 38: 415-23. PMID 23802888 DOI: 10.1111/apt.12391  0.347
2013 Dai CY, Tseng TC, Wong GL, Huang JF, Wong VW, Liu CJ, Yu ML, Chuang WL, Kao JH, Chan HL, Chen DS. Consolidation therapy for HBeAg-positive Asian chronic hepatitis B patients receiving lamivudine treatment: a multicentre study. The Journal of Antimicrobial Chemotherapy. 68: 2332-8. PMID 23798667 DOI: 10.1093/jac/dkt193  0.329
2013 Chen GY, Su TH, Kao JH. Successful treatment of chronic hepatitis B and D with pegylated-interferon plus entecavir. Journal of the Formosan Medical Association = Taiwan Yi Zhi. PMID 23791143 DOI: 10.1016/j.jfma.2013.05.011  0.397
2013 Lin CL, Kao JH. Hepatitis B viral factors and treatment responses in chronic hepatitis B. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 112: 302-11. PMID 23787007 DOI: 10.1016/j.jfma.2013.02.001  0.377
2013 Liu CJ, Kao JH. Global perspective on the natural history of chronic hepatitis B: role of hepatitis B virus genotypes A to J. Seminars in Liver Disease. 33: 97-102. PMID 23749665 DOI: 10.1055/s-0033-1345716  0.403
2013 Huang YW, Lin SC, Wei SC, Hu JT, Chang HY, Huang SH, Chen DS, Chen PJ, Hsu PN, Yang SS, Kao JH. Reduced Toll-like receptor 3 expression in chronic hepatitis B patients and its restoration by interferon therapy. Antiviral Therapy. 18: 877-84. PMID 23744559 DOI: 10.3851/IMP2630  0.361
2013 Tseng TC, Liu CJ, Chen CL, Yang HC, Su TH, Wang CC, Yang WT, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Risk stratification of hepatocellular carcinoma in hepatitis B virus e antigen-negative carriers by combining viral biomarkers. The Journal of Infectious Diseases. 208: 584-93. PMID 23656977 DOI: 10.1093/Infdis/Jit209  0.364
2013 Su TH, Liu CJ, Tseng TC, Liu CH, Yang HC, Chen CL, Chen PJ, Kao JH, Chen DS. Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection. Plos One. 8: e55916. PMID 23437072 DOI: 10.1371/Journal.Pone.0055916  0.388
2013 Yu ML, Lee CM, Chen CL, Chuang WL, Lu SN, Liu CH, Wu SS, Liao LY, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Su WW, Lin CL, et al. Sustained hepatitis C virus clearance and increased hepatitis B surface antigen seroclearance in patients with dual chronic hepatitis C and B during posttreatment follow-up. Hepatology (Baltimore, Md.). 57: 2135-42. PMID 23322699 DOI: 10.1002/Hep.26266  0.403
2013 Hsu CS, Kao JH. Fluvastatin helps interferon-based therapy in chronic hepatitis C: fact or fiction? Journal of Gastroenterology and Hepatology. 28: 7-9. PMID 23278153 DOI: 10.1111/jgh.12024  0.336
2013 Huang CF, Yu ML, Kao JH, Tseng TC, Yeh ML, Huang JF, Dai CY, Lin ZY, Chen SC, Wang LY, Juo SH, Chuang WL, Liu CH. Profound week 4 interferon responsiveness is mandatory for hepatitis C genotype 1 patients with unfavorable IL-28B genotype. Journal of Clinical Virology : the Official Publication of the Pan American Society For Clinical Virology. 56: 293-8. PMID 23246359 DOI: 10.1016/j.jcv.2012.11.015  0.348
2013 Yang HC, Chen CL, Shen YC, Peng CY, Liu CJ, Tseng TC, Su TH, Chuang WL, Yu ML, Dai CY, Liu CH, Chen PJ, Chen DS, Kao JH. Distinct evolution and predictive value of hepatitis B virus precore and basal core promoter mutations in interferon-induced hepatitis B e antigen seroconversion. Hepatology (Baltimore, Md.). 57: 934-43. PMID 23112104 DOI: 10.1002/hep.26121  0.32
2013 Lin CL, Kao JH. Risk stratification for hepatitis B virus related hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 28: 10-7. PMID 23094699 DOI: 10.1111/jgh.12010  0.363
2013 Tseng TC, Kao JH. Clinical utility of quantitative HBsAg in natural history and nucleos(t)ide analogue treatment of chronic hepatitis B: new trick of old dog. Journal of Gastroenterology. 48: 13-21. PMID 23090000 DOI: 10.1007/s00535-012-0668-y  0.404
2013 Huang YW, Hu JT, Hu FC, Chang CJ, Chang HY, Kao JH, Yang SS, Chen DS. Biphasic pattern of depression and its predictors during pegylated interferon-based therapy in chronic hepatitis B and C patients. Antiviral Therapy. 18: 567-73. PMID 23072880 DOI: 10.3851/IMP2441  0.344
2013 Wang CC, Tseng KC, Peng CY, Hsieh TY, Lin CL, Su TH, Tseng TC, Hsu CS, Lin HH, Kao JH. Viral load and alanine aminotransferase correlate with serologic response in chronic hepatitis B patients treated with entecavir. Journal of Gastroenterology and Hepatology. 28: 46-50. PMID 22989322 DOI: 10.1111/j.1440-1746.2012.07269.x  0.377
2013 Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Hsu CA, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Serum hepatitis B surface antigen levels help predict disease progression in patients with low hepatitis B virus loads. Hepatology (Baltimore, Md.). 57: 441-50. PMID 22941922 DOI: 10.1002/Hep.26041  0.413
2013 Yuan Q, Song LW, Liu CJ, Li Z, Liu PG, Huang CH, Yan Y, Ge SX, Wang YB, Peng CY, Zhang J, Kao JH, Chen DS, Chen PJ, Xia NS. Quantitative hepatitis B core antibody level may help predict treatment response in chronic hepatitis B patients. Gut. 62: 182-4. PMID 22698651 DOI: 10.1136/gutjnl-2012-302656  0.371
2013 Liu CJ, Chen PJ, Chen DS, Kao JH. Hepatitis B virus reactivation in patients receiving cancer chemotherapy: natural history, pathogenesis, and management. Hepatology International. 7: 316-26. PMID 21670970 DOI: 10.1007/s12072-011-9279-6  0.392
2013 Liu CJ, Kao JH. Treatment options for dual HCV/HBV coinfection Emerging Therapeutic Options For Hepatitis C. 73-84. DOI: 10.2217/EBO.12.276  0.449
2013 Liu C, Wang C, Yang S, Su C, Liao L, Lee T, Chuang W, Chen C, Chien R, Peng C, Lee C, Lee Y, Kao J, Chen P, Chen D. 758 ENTECAVIR PLUS PEGINTERFERON alfa-2a vs. ENTECAVIR ALONE IN THE TREATMENT OF HEPATITIS B e ANTIGEN-POSITIVE CHRONIC HEPATITIS B: AN INTERIM REPORT Journal of Hepatology. 58: S308. DOI: 10.1016/S0168-8278(13)60760-6  0.347
2013 Tseng TC, Kao JH. Evolution of viral biomarkers in predicting outcomes of chronic hepatitis B patients: From DNA to surface antigen Tzu Chi Medical Journal. 25: 75-81. DOI: 10.1016/j.tcmj.2013.03.005  0.378
2013 Liu CH, Kao JH. IL28B genotype on HCV infection in Asia Current Hepatitis Reports. 12: 149-156. DOI: 10.1007/s11901-013-0176-4  0.34
2013 Lin CL, Kao JH. Hepatitis B virus genotypes: Clinical relevance and therapeutic implications Current Hepatitis Reports. 12: 124-132. DOI: 10.1007/s11901-013-0166-6  0.407
2012 Liaw YF, Kao JH, Piratvisuth T, Chan HL, Chien RN, Liu CJ, Gane E, Locarnini S, Lim SG, Han KH, Amarapurkar D, Cooksley G, Jafri W, Mohamed R, Hou JL, et al. Erratum to: Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatology International. 6: 809-10. PMID 26201529 DOI: 10.1007/s12072-012-9386-z  0.328
2012 Liaw YF, Kao JH, Piratvisuth T, Chan HL, Chien RN, Liu CJ, Gane E, Locarnini S, Lim SG, Han KH, Amarapurkar D, Cooksley G, Jafri W, Mohamed R, Hou JL, et al. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update. Hepatology International. 6: 531-61. PMID 26201469 DOI: 10.1007/s12072-012-9365-4  0.4
2012 Omata M, Kanda T, Yu ML, Yokosuka O, Lim SG, Jafri W, Tateishi R, Hamid SS, Chuang WL, Chutaputti A, Wei L, Sollano J, Sarin SK, Kao JH, McCaughan GW. APASL consensus statements and management algorithms for hepatitis C virus infection. Hepatology International. 6: 409-35. PMID 26201405 DOI: 10.1007/s12072-012-9342-y  0.318
2012 Yu ML, Liu CH, Huang CF, Tseng TC, Huang JF, Dai CY, Lin ZY, Chen SC, Wang LY, Juo SH, Chuang WL, Kao JH. Revisiting the stopping rule for hepatitis C genotype 1 patients treated with peginterferon plus ribavirin. Plos One. 7: e52048. PMID 23284866 DOI: 10.1371/journal.pone.0052048  0.372
2012 Tseng TC, Liu CJ, Su TH, Yang HC, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Young chronic hepatitis B patients with nucleos(t)ide analogue-induced hepatitis B e antigen seroconversion have a higher risk of HBV reactivation. The Journal of Infectious Diseases. 206: 1521-31. PMID 22966125 DOI: 10.1093/Infdis/Jis569  0.356
2012 Hsu CS, Kao JH. Genomic variation-guided management in chronic hepatitis C. Expert Review of Gastroenterology & Hepatology. 6: 497-506. PMID 22928901 DOI: 10.1586/egh.12.24  0.342
2012 Kao JH, Liu CJ, Jow GM, Chen PJ, Chen DS, Chen BF. Fine mapping of hepatitis B virus pre-S deletion and its association with hepatocellular carcinoma. Liver International : Official Journal of the International Association For the Study of the Liver. 32: 1373-81. PMID 22676233 DOI: 10.1111/j.1478-3231.2012.02826.x  0.334
2012 Chen SH, Wu HL, Kao JH, Hwang LH. Persistent hepatitis B viral replication in a FVB/N mouse model: impact of host and viral factors. Plos One. 7: e36984. PMID 22615863 DOI: 10.1371/journal.pone.0036984  0.316
2012 Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. High levels of hepatitis B surface antigen increase risk of hepatocellular carcinoma in patients with low HBV load. Gastroenterology. 142: 1140-1149.e3; quiz e. PMID 22333950 DOI: 10.1053/J.Gastro.2012.02.007  0.363
2012 Liu CH, Liang CC, Liu CJ, Tseng TC, Lin CL, Yang SS, Su TH, Hsu SJ, Lin JW, Chen JH, Chen PJ, Chen DS, Kao JH. Interleukin 28B genetic polymorphisms and viral factors help identify HCV genotype-1 patients who benefit from 24-week pegylated interferon plus ribavirin therapy. Antiviral Therapy. 17: 477-84. PMID 22301466 DOI: 10.3851/IMP2026  0.3
2012 Sheng WH, Hung CC, Chang SY, Liu CJ, Chen MY, Hsieh SM, Kao JH, Chen PJ, Chang SC. Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 54: 548-55. PMID 22156858 DOI: 10.1093/cid/cir851  0.371
2012 Tseng TC, Liu CJ, Chen CL, Wang CC, Su TH, Kuo SF, Chen PJ, Chen DS, Kao JH. Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters. The Journal of Infectious Diseases. 205: 54-63. PMID 22095766 DOI: 10.1093/infdis/jir687  0.352
2012 Tseng TC, Kao JH. Hepatitis B virus mutants associated with hepatitis B surface antigen loss: chicken or egg? Hepatology (Baltimore, Md.). 55: 656-7. PMID 21969004 DOI: 10.1002/hep.24718  0.347
2012 Tsai HB, Chen PC, Liu CH, Hung PH, Chen MT, Chiang CK, Kao JH, Hung KY. Association of hepatitis C virus infection and malnutrition-inflammation complex syndrome in maintenance hemodialysis patients. Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association. 27: 1176-83. PMID 21896499 DOI: 10.1093/ndt/gfr458  0.352
2012 Tseng TC, Liu CJ, Yang HC, Su TH, Wang CC, Chen CL, Kuo SF, Liu CH, Chen PJ, Chen DS, Kao JH. Determinants of spontaneous surface antigen loss in hepatitis B e antigen-negative patients with a low viral load. Hepatology (Baltimore, Md.). 55: 68-76. PMID 21858846 DOI: 10.1002/Hep.24615  0.33
2012 Lin CL, Tseng TC, Su TH, Liu CJ, Chen PJ, Lai MY, Chen DS, Kao JH. Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission. Hepatology International. 6: 598-605. PMID 21779934 DOI: 10.1007/s12072-011-9297-4  0.359
2012 Liu C, Chuang W, Lee C, Yu M, Lu S, Wu S, Liao L, Chen C, Kuo H, Chao Y, Tung S, Yang S, Kao J, Liu C, Su W, et al. 527 SUSTAINED HCV CLEARANCE AND INCREASED HBSAG SEROCLEARANCE IN PATIENTS WITH DUAL CHRONIC HEPATITIS C AND B POST-PEGINTERFERON ALFA-2A AND RIBAVIRIN TREATMENT: A 5-YEAR FOLLOW-UP Journal of Hepatology. 56: S209. DOI: 10.1016/S0168-8278(12)60540-6  0.367
2011 Wu LW, Kao JH. Hepatitis during antituberculosis treatment. Journal of the Formosan Medical Association = Taiwan Yi Zhi. 110: 801. PMID 22248841 DOI: 10.1016/j.jfma.2011.11.017  0.326
2011 Kao JH. Molecular epidemiology of hepatitis B virus. The Korean Journal of Internal Medicine. 26: 255-61. PMID 22016585 DOI: 10.3904/kjim.2011.26.3.255  0.455
2011 Tseng TC, Yu ML, Liu CJ, Lin CL, Huang YW, Hsu CS, Liu CH, Kuo SF, Pan CJ, Yang SS, Su CW, Chen PJ, Chen DS, Kao JH. Effect of host and viral factors on hepatitis B e antigen-positive chronic hepatitis B patients receiving pegylated interferon-α-2a therapy. Antiviral Therapy. 16: 629-37. PMID 21817184 DOI: 10.3851/IMP1841  0.345
2011 Chan HL, Thompson A, Martinot-Peignoux M, Piratvisuth T, Cornberg M, Brunetto MR, Tillmann HL, Kao JH, Jia JD, Wedemeyer H, Locarnini S, Janssen HL, Marcellin P. Hepatitis B surface antigen quantification: why and how to use it in 2011 - a core group report. Journal of Hepatology. 55: 1121-31. PMID 21718667 DOI: 10.1016/J.Jhep.2011.06.006  0.373
2011 Yeh ML, Hung CH, Huang JF, Liu CJ, Lee CM, Dai CY, Wang JH, Lin ZY, Lu SN, Hu TH, Yu ML, Kao JH, Chuang WL, Chen PJ, Chen DS. Long-term effect of interferon plus ribavirin on hepatitis B surface antigen seroclearance in patients dually infected with hepatitis B and C viruses. Plos One. 6: e20752. PMID 21695152 DOI: 10.1371/journal.pone.0020752  0.418
2011 Lin CL, Kao JH. Recent advances in the treatment of chronic hepatitis B. Expert Opinion On Pharmacotherapy. 12: 2025-40. PMID 21682661 DOI: 10.1517/14656566.2011.590474  0.334
2011 Nien HC, Sheu JC, Kao JH, Chou HC, Su CW, Chen CH. Aboriginal Taiwanese hepatitis B carriers have more favorable viral factors than Han Chinese carriers. Journal of Medical Virology. 83: 1326-31. PMID 21678436 DOI: 10.1002/jmv.22135  0.379
2011 Tseng TC, Liu CJ, Su TH, Wang CC, Chen CL, Chen PJ, Chen DS, Kao JH. Serum hepatitis B surface antigen levels predict surface antigen loss in hepatitis B e antigen seroconverters. Gastroenterology. 141: 517-25, 525.e1-2. PMID 21672542 DOI: 10.1053/j.gastro.2011.04.046  0.353
2011 Wang JY, Liu CH, Hu FC, Chang HC, Liu JL, Chen JM, Yu CJ, Lee LN, Kao JH, Yang PC. Risk factors of hepatitis during anti-tuberculous treatment and implications of hepatitis virus load. The Journal of Infection. 62: 448-55. PMID 21570123 DOI: 10.1016/j.jinf.2011.04.005  0.394
2011 Liang CC, Liu CH, Lin YL, Liu CJ, Chiang BL, Kao JH. Functional impairment of dendritic cells in patients infected with hepatitis C virus genotype 1 who failed peginterferon plus ribavirin therapy. Journal of Medical Virology. 83: 1212-20. PMID 21567425 DOI: 10.1002/jmv.22096  0.325
2011 Mah YH, Hsu CS, Liu CH, Liu CJ, Lai MY, Chen PJ, Chen DS, Kao JH. Serum p53 gene polymorphisms and severity of hepatitis B or C-related chronic liver diseases in Taiwan. Hepatology International. 5: 814-21. PMID 21484135 DOI: 10.1007/s12072-010-9248-5  0.327
2011 Batoctoy KS, Tseng TC, Kao JH, Quiza FE, Garcia LH, Lao-Tan J. HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City, Philippines. Hepatology International. 5: 774-81. PMID 21484121 DOI: 10.1007/s12072-011-9263-1  0.43
2011 Hsu SJ, Hsu CS, Liu CH, Liu CJ, Chen CL, Chen PJ, Chen DS, Kao JH. HCV core gene polymorphisms correlate with liver fibrosis but not sustained virological response in patients with genotype 1 infection. Antiviral Therapy. 16: 227-35. PMID 21447872 DOI: 10.3851/IMP1741  0.327
2011 Liu CH, Liang CC, Huang KW, Liu CJ, Chen SI, Lin JW, Hung PH, Tsai HB, Lai MY, Chen PJ, Chen JH, Chen DS, Kao JH. Transient elastography to assess hepatic fibrosis in hemodialysis chronic hepatitis C patients. Clinical Journal of the American Society of Nephrology : Cjasn. 6: 1057-65. PMID 21393486 DOI: 10.2215/CJN.04320510  0.382
2011 Hsu CS, Hsu SJ, Chen HC, Tseng TC, Liu CH, Niu WF, Jeng J, Liu CJ, Lai MY, Chen PJ, Kao JH, Chen DS. Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients with IFN plus ribavirin therapy. Proceedings of the National Academy of Sciences of the United States of America. 108: 3719-24. PMID 21321200 DOI: 10.1073/pnas.1100349108  0.344
2011 Wen WH, Chen HL, Ni YH, Hsu HY, Kao JH, Hu FC, Chang MH. Secular trend of the viral genotype distribution in children with chronic hepatitis B virus infection after universal infant immunization. Hepatology (Baltimore, Md.). 53: 429-36. PMID 21274864 DOI: 10.1002/hep.24061  0.311
2011 Liu CH, Kao JH. Treatment of hepatitis C virus infection in patients with end-stage renal disease. Journal of Gastroenterology and Hepatology. 26: 228-39. PMID 21261711 DOI: 10.1111/j.1440-1746.2010.06488.x  0.382
2011 Ochi H, Maekawa T, Abe H, Hayashida Y, Nakano R, Imamura M, Hiraga N, Kawakami Y, Aimitsu S, Kao JH, Kubo M, Tsunoda T, Kumada H, Nakamura Y, Hayes CN, et al. IL-28B predicts response to chronic hepatitis C therapy--fine-mapping and replication study in Asian populations. The Journal of General Virology. 92: 1071-81. PMID 21228123 DOI: 10.1099/vir.0.029124-0  0.318
2011 Lin CL, Kao JH. The clinical implications of hepatitis B virus genotype: Recent advances. Journal of Gastroenterology and Hepatology. 26: 123-30. PMID 21199523 DOI: 10.1111/j.1440-1746.2010.06541.x  0.419
2011 Hsu C, Chen D, Kao J. CS1.4 Association of IL28B gene variations with mathematical modeling of viral kinetics in chronic hepatitis C patients International Journal of Infectious Diseases. 15: S1-S2. DOI: 10.1016/S1201-9712(11)60008-8  0.311
2011 Kao JH. Control by Vaccination: Asian and Taiwan Experience Clinical Dilemmas in Primary Liver Cancer. 18-23. DOI: 10.1002/9781119962205.ch3  0.367
2010 Su TH, Hsu CS, Chen CL, Liu CH, Huang YW, Tseng TC, Liu CJ, Chen PJ, Lai MY, Chen DS, Kao JH. Serum hepatitis B surface antigen concentration correlates with HBV DNA level in patients with chronic hepatitis B. Antiviral Therapy. 15: 1133-9. PMID 21149920 DOI: 10.3851/IMP1696  0.363
2010 Hsu CS, Wang CC, Wang PC, Lin HH, Tseng TC, Chen CH, Su WC, Liu CJ, Chen CL, Lai MY, Chen PJ, Chen DS, Kao JH. Increased incidence of gastroesophageal reflux disease in patients with chronic hepatitis B virus infection. Hepatology International. 4: 585-93. PMID 21063481 DOI: 10.1007/s12072-010-9184-4  0.382
2010 Tong MJ, Hsu L, Hsien C, Kao JH, Durazo FA, Saab S, Blatt LM. A comparison of hepatitis B viral markers of patients in different clinical stages of chronic infection. Hepatology International. 4: 516-22. PMID 20827410 DOI: 10.1007/s12072-010-9179-1  0.39
2010 Huang ZS, Huang TS, Wu TH, Chen MF, Hsu CS, Kao JH. Asymptomatic chronic hepatitis B virus infection does not increase the risk of diabetes mellitus: a ten-year observation. Journal of Gastroenterology and Hepatology. 25: 1420-5. PMID 20659233 DOI: 10.1111/j.1440-1746.2010.06268.x  0.344
2010 Liu CH, Liang CC, Liu CJ, Lin JW, Chen SI, Hung PH, Tsai HB, Lai MY, Chen PJ, Chen DS, Kao JH. Pegylated interferon alfa-2a monotherapy for hemodialysis patients with acute hepatitis C. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 51: 541-9. PMID 20645865 DOI: 10.1086/655682  0.393
2010 Sung JJ, Amarapurkar D, Chan HL, Cheng J, Kao JH, Han KH, Piratvisuth T. Treatment of chronic hepatitis B in Asia-Pacific countries: is the Asia-Pacific consensus statement being followed? Antiviral Therapy. 15: 607-16. PMID 20587854 DOI: 10.3851/IMP1561  0.335
2010 Wang CC, Kao JH. Rifaximin treatment in hepatic encephalopathy. The New England Journal of Medicine. 362: 2423; author reply 2. PMID 20573932 DOI: 10.1056/NEJMc1004719  0.329
2010 Hsu CS, Liu CH, Liu CJ, Hsu SJ, Chen CL, Hwang JJ, Lai MY, Chen PJ, Chen DS, Kao JH. Association of metabolic profiles with hepatic fibrosis in chronic hepatitis C patients with genotype 1 or 2 infection Journal of Gastroenterology and Hepatology (Australia). 25: 970-977. PMID 20546452 DOI: 10.1111/j.1440-1746.2009.06186.x  0.371
2010 Lin CL, Kao JH. Clinical implications of hepatitis B virus variants Journal of the Formosan Medical Association. 109: 321-325. PMID 20514738 DOI: 10.1016/S0929-6646(10)60059-9  0.347
2010 Yu ML, Lee CM, Chuang WL, Lu SN, Dai CY, Huang JF, Lin ZY, Hu TI, Chen CH, Hung C, Wang JH, Chen CL, Kao JH, Lai MY, Liu CH, et al. HBsAg profiles in patients receiving peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses Journal of Infectious Diseases. 202: 86-92. PMID 20482252 DOI: 10.1086/653209  0.436
2010 Huang YW, Chayama K, Tsuge M, Takahashi S, Hatakeyama T, Abe H, Hu JT, Liu CJ, Lai MY, Chen DS, Yang SS, Kao JH. Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B. Antiviral Therapy. 15: 177-84. PMID 20386072 DOI: 10.3851/IMP1508  0.305
2010 Liu CH, Liang CC, Liu CJ, Hsu SJ, Lin JW, Chen SI, Hung PH, Tsai HB, Lai MY, Chen PJ, Chen JH, Chen DS, Kao JH. The ratio of aminotransferase to platelets is a useful index for predicting hepatic fibrosis in hemodialysis patients with chronic hepatitis C. Kidney International. 78: 103-9. PMID 20357753 DOI: 10.1038/ki.2010.74  0.357
2010 Liaw YF, Lau GK, Kao JH, Gane E. Hepatitis B e antigen seroconversion: a critical event in chronic hepatitis B virus infection. Digestive Diseases and Sciences. 55: 2727-34. PMID 20238245 DOI: 10.1007/s10620-010-1179-4  0.43
2010 Hsu CS, Kao JH. Role of Viral Factors in Modifying Weight-Related Effects on Disease Progression of Chronic Hepatitis C Patients Gastroenterology. 138: 788-789. PMID 20026441 DOI: 10.1053/j.gastro.2009.09.078  0.318
2010 Tseng TC, Liu CJ, Kao JH. Implications of hepatitis B virus genomic variations on treatment outcomes Current Pharmacogenomics and Personalized Medicine. 8: 280-288. DOI: 10.2174/187569210793368195  0.393
2010 Kao JH, Chen PJ, Chen DS. Recent advances in the research of hepatitis B virus-related hepatocellular carcinoma. Epidemiologic and molecular biological aspects Advances in Cancer Research. 108: 21-72. DOI: 10.1016/B978-0-12-380888-2.00002-9  0.336
2009 Hsieh TH, Tseng TC, Liu CJ, Lai MY, Chen PJ, Hsieh HL, Chen DS, Kao JH. Hepatitis B virus genotype B has an earlier emergence of lamivudine resistance than genotype C Antiviral Therapy. 14: 1157-1163. PMID 20032545 DOI: 10.3851/IMP1454  0.345
2009 Tseng TC, Liu CJ, Wang CC, Chen PJ, Lai MY, Chen DS, Kao JH. Association of baseline viral factors with response to lamivudine therapy in chronic hepatitis B patients with high serum alanine aminotransferase levels. Antiviral Therapy. 14: 203-10. PMID 19430095  0.385
2009 Hsu CS, Liu CH, Liu CJ, Wang CC, Chen CL, Lai MY, Chen PJ, Chen DS, Kao JH. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection. The American Journal of Gastroenterology. 104: 598-604. PMID 19262519 DOI: 10.1038/ajg.2008.125  0.389
2009 Tong MJ, Hsien C, Song JJ, Kao JH, Sun HE, Hsu L, Han SH, Durazo FA, Saab S, Blatt LM. Factors associated with progression to hepatocellular carcinoma and to death from liver complications in patients with HBsAg-positive cirrhosis. Digestive Diseases and Sciences. 54: 1337-46. PMID 19242792 DOI: 10.1007/s10620-009-0747-y  0.348
2009 Huang YW, Hu CY, Chen CL, Liao YT, Liu CJ, Lai MY, Chen PJ, Yang SS, Hu JT, Chen DS, Kao JH. Human leukocyte antigen-DRB1*1101 correlates with less severe hepatitis in Taiwanese male carriers of hepatitis B virus. Journal of Medical Virology. 81: 588-93. PMID 19235869 DOI: 10.1002/jmv.21448  0.357
2009 Liu CJ, Jeng YM, Chen CL, Cheng HR, Chen PJ, Chen TC, Liu CH, Lai MY, Chen DS, Kao JH. Hepatitis B virus basal core promoter mutation and DNA load correlate with expression of hepatitis B core antigen in patients with chronic hepatitis B Journal of Infectious Diseases. 199: 742-749. PMID 19199543 DOI: 10.1086/596655  0.371
2009 Liu CJ, Chuang WL, Lee CM, Yu ML, Lu SN, Wu SS, Liao LY, Chen CL, Kuo HT, Chao YC, Tung SY, Yang SS, Kao JH, Liu CH, Su WW, et al. Peginterferon alfa-2a plus ribavirin for the treatment of dual chronic infection with hepatitis B and C viruses. Gastroenterology. 136: 496-504.e3. PMID 19084016 DOI: 10.1053/j.gastro.2008.10.049  0.383
2009 Chuang JY, Yang SS, Lu YT, Hsieh YY, Chen CY, Chang SC, Chang CS, Yeh HZ, Kao JH. IL-10 promoter gene polymorphisms and sustained response to combination therapy in Taiwanese chronic hepatitis C patients. Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association For the Study of the Liver. 41: 424-30. PMID 19004675 DOI: 10.1016/j.dld.2008.09.017  0.37
2009 Mah Y, Hsu C, Liu C, Liu C, Lai M, Chen P, Chen D, Kao J. The Impact of p53 Mutations on the Course of Hepatitis B or C-related Chronic Liver Diseases in Taiwan American Journal of Gastroenterology. 104: S148. DOI: 10.14309/00000434-200910003-00395  0.316
2009 Lim SG, Mohammed R, Yuen MF, Kao JH. Prevention of hepatocellular carcinoma in hepatitis B virus infection Journal of Gastroenterology and Hepatology (Australia). 24: 1352-1357. DOI: 10.1111/J.1440-1746.2009.05985.X  0.408
2009 Huang Y, Chayama K, Tsuge M, Takahashi S, Hatakeyama T, Abe H, Imamura M, Hu J, Liu C, Lai M, Chen P, Chen D, Yang S, Kao J. OL-029 Differential effects of interferon and lamivudine on serum HBV RNA inhibition in patients with chronic hepatitis B International Journal of Infectious Diseases. 13: S39-S40. DOI: 10.1016/S1201-9712(09)60358-1  0.358
2009 Liu C, Chuang W, Lee C, Yu M, Lu S, Wu S, Liao L, Kuo H, Chao Y, Tung S, Yang S, Kao J, Liu C, Chen P, Chen D. PL-005 Profile of HBsAg levels in patients with dual hepatitis B virus and hepatitis C virus infection treated with peginterferon alfa-2a and ribavirin International Journal of Infectious Diseases. 13: S28. DOI: 10.1016/S1201-9712(09)60323-4  0.394
2009 Tseng T, Liu C, Wang C, Chen P, Lai M, Chen D, Kao J. 381 SERUM HEPATITIS B VIRUS DNA LEVEL AT ONE YEAR AFTER HEPATITIS B E ANTIGEN SEROCONVERSION PREDICTS SUBSEQUENT HEPATITIS B REACTIVATION Journal of Hepatology. 50: S145. DOI: 10.1016/S0168-8278(09)60383-4  0.362
2009 Liu C, Chuang W, Lee C, Yu M, Lu S, Wu S, Liao L, Chen C, Kuo H, Chao Y, Tung S, Yang S, Kao J, Liu C, Su W, et al. 16 ANALYSIS OF HBsAg LEVELS IN PATIENTS COINFECTED WITH HEPATITIS B VIRUS AND HEPATITIS C VIRUS TREATED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN Journal of Hepatology. 50: S9. DOI: 10.1016/S0168-8278(09)60018-0  0.389
2009 Liu CJ, Chen PJ, Lai MY, Liu CH, Chen CL, Kao JH, Chen DS. High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection Hepatology International. 3: 364-370. DOI: 10.1007/s12072-008-9111-0  0.397
2008 Liaw YF, Leung N, Kao JH, Piratvisuth T, Gane E, Han KH, Guan R, Lau GK, Locarnini S. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2008 update. Hepatology International. 2: 263-83. PMID 19669255 DOI: 10.1007/s12072-008-9080-3  0.385
2008 Kao JH. Diagnosis of hepatitis B virus infection through serological and virological markers Expert Review of Gastroenterology and Hepatology. 2: 553-562. PMID 19072403 DOI: 10.1586/17474124.2.4.553  0.422
2008 Su TH, Liu CJ, Chen PJ, Chen DS, Kao JH. Acute fatty liver of pregnancy with concurrent acute hepatitis B virus infection American Journal of Gastroenterology. 103: 2663-2665. PMID 18855869 DOI: 10.1111/j.1572-0241.2008.02074_13.x  0.327
2008 Tsai YH, Kuang WF, Lu TY, Kao JH, Lai MY, Liu CJ, Chen PJ, Hwang LH. The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism. Journal of Hepatology. 49: 899-907. PMID 18842320 DOI: 10.1016/j.jhep.2008.06.030  0.324
2008 Liu CH, Liu CJ, Lin CL, Liang CC, Hsu SJ, Yang SS, Hsu CS, Tseng TC, Wang CC, Lai MY, Chen JH, Chen PJ, Chen DS, Kao JH. Pegylated interferon-alpha-2a plus ribavirin for treatment-naive Asian patients with hepatitis C virus genotype 1 infection: a multicenter, randomized controlled trial. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 47: 1260-9. PMID 18834319 DOI: 10.1086/592579  0.352
2008 Tseng TC, Liu CJ, Wang CC, Chen PJ, Lai MY, Kao JH, Chen DS. A higher alanine aminotransferase level correlates with earlier hepatitis B e antigen seroconversion in lamivudine-treated chronic hepatitis B patients. Liver International : Official Journal of the International Association For the Study of the Liver. 28: 1034-41. PMID 18492018 DOI: 10.1111/j.1478-3231.2008.01766.x  0.39
2008 Tseng TC, Kao JH. HBV Genotype and Clinical Outcome of Chronic Hepatitis B: Facts and Puzzles Gastroenterology. 134: 1272-1273. PMID 18395116 DOI: 10.1053/j.gastro.2007.12.046  0.368
2008 Lin CL, Branch RA, Kao JH. Combination of Hepatitis B Viral Factors and Advanced Liver Disease in HBeAg-Negative Patients: The More, the Worse? Gastroenterology. 134: 1270-1271. PMID 18395114 DOI: 10.1053/j.gastro.2007.12.045  0.37
2008 Lin CL, Kao JH. Hepatitis B viral factors and clinical outcomes of chronic hepatitis B Journal of Biomedical Science. 15: 137-145. PMID 18058038 DOI: 10.1007/s11373-007-9225-8  0.436
2008 Wang CC, Hsu CS, Liu CJ, Kao JH, Chen DS. Association of chronic hepatitis B virus infection with insulin resistance and hepatic steatosis. Journal of Gastroenterology and Hepatology. 23: 779-82. PMID 18028349 DOI: 10.1111/j.1440-1746.2007.05216.x  0.357
2008 Hsu CS, Liu CJ, Liu CH, Wang CC, Chen CL, Lai MY, Chen PJ, Kao JH, Chen DS. High hepatitis C viral load is associated with insulin resistance in patients with chronic hepatitis C. Liver International : Official Journal of the International Association For the Study of the Liver. 28: 271-7. PMID 18028320 DOI: 10.1111/j.1478-3231.2007.01626.x  0.353
2008 Hwang Y, Lau G, Kao J, Chuang W, Peng C, Zhang X, Wan M, Liang K, Chao E, Chen E. OL-015 A pharmacogenomics approach to predict the efficacy of HBeAg-positive chronic hepatitis B patients with pegylated interferon treatment International Journal of Infectious Diseases. 12: S39-S40. DOI: 10.1016/S1201-9712(09)60112-0  0.345
2008 Kao J. I-53 Treatment of chronic hepatitis C in Taiwan International Journal of Infectious Diseases. 12: S19. DOI: 10.1016/S1201-9712(09)60056-4  0.331
2008 Kao JH, Chen DS. Critical analysis of the immune tolerance phase of chronic HBV infection: Natural history and diagnosis Current Hepatitis Reports. 7: 5-11. DOI: 10.1007/s11901-008-0015-1  0.384
2007 Kao JH. Role of viral factors in the natural course and therapy of chronic hepatitis B. Hepatology International. 1: 415-30. PMID 19669337 DOI: 10.1007/s12072-007-9033-2  0.439
2007 Sheng WH, Kao JH, Chen PJ, Huang LM, Chang SY, Sun HY, Hung CC, Chen MY, Chang SC. Evolution of hepatitis B serological markers in HIV-infected patients receiving highly active antiretroviral therapy. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 45: 1221-9. PMID 17918088 DOI: 10.1086/522173  0.302
2007 Liu CH, Hsu SJ, Lin JW, Hwang JJ, Liu CJ, Yang PM, Lai MY, Chen PJ, Chen JH, Kao JH, Chen DS. Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 5: 1199-1206.e1. PMID 17916547 DOI: 10.1016/j.cgh.2007.07.017  0.394
2007 Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG. Basal core promoter T1762/A1764 and precore A1896 gene mutations in hepatitis B surface antigen-positive hepatocellular carcinoma: A comparison with chronic carriers Liver International. 27: 1356-1363. PMID 17900245 DOI: 10.1111/j.1478-3231.2007.01585.x  0.314
2007 Lin CL, Liu CJ, Chen PJ, Lai MY, Chen DS, Kao JH. High prevalence of occult hepatitis B virus infection in Taiwanese intravenous drug users. Journal of Medical Virology. 79: 1674-8. PMID 17854041 DOI: 10.1002/JMV.20985  0.307
2007 Tseng TC, Liu CJ, Chen PJ, Lai MY, Lin CL, Kao JH, Chen DS. Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan. Liver International : Official Journal of the International Association For the Study of the Liver. 27: 983-8. PMID 17696938 DOI: 10.1111/j.1478-3231.2007.01546.x  0.423
2007 Hsu CS, Liu CJ, Lai MY, Chen PJ, Kao JH, Chen DS. Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan. Intervirology. 50: 310-5. PMID 17622791 DOI: 10.1159/000105444  0.358
2007 Lin CL, Liu CH, Chen W, Huang WL, Chen PJ, Lai MY, Chen DS, Kao JH. Association of pre-S deletion mutant of hepatitis B virus with risk of hepatocellular carcinoma. Journal of Gastroenterology and Hepatology. 22: 1098-103. PMID 17608857 DOI: 10.1111/j.1440-1746.2006.04515.x  0.338
2007 Tseng TC, Liu CJ, Kao JH. Sequential combination therapy for chronic hepatitis B: More challenges to be tackled [7] American Journal of Gastroenterology. 102: 1544. PMID 17593169 DOI: 10.1111/j.1572-0241.2007.01261.x  0.352
2007 Lin C, Kao JH. To genotype or not to genotype: Toward an optimal tailoring of treatment of chronic hepatitis B [3] Clinical Infectious Diseases. 44: 1665-1666. PMID 17516416 DOI: 10.1086/518386  0.33
2007 Liu CJ, Kao JH. Hepatitis B virus-related hepatocellular carcinoma: Epidemiology and pathogenic role of viral factors Journal of the Chinese Medical Association. 70: 141-145. PMID 17475593 DOI: 10.1016/S1726-4901(09)70346-6  0.376
2007 Sheng WH, Hung CC, Kao JH, Chang SY, Chen MY, Hsieh SM, Chen PJ, Chang SC. Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 44: 988-95. PMID 17342655 DOI: 10.1086/511867  0.35
2007 Wang CC, Liu CJ, Lai MY, Kao JH, Chen DS. Dynamics of hepatitis B e antigen index ratio correlate with treatment response in chronic hepatitis B patients. Liver International : Official Journal of the International Association For the Study of the Liver. 27: 235-9. PMID 17311619 DOI: 10.1111/j.1478-3231.2006.01418.x  0.411
2007 Liu CH, Liu CJ, Kao JH. Interferon-based therapy for dialysis patients with chronic hepatitis C: Progress and challenges Nephrology. 12: 8-10. PMID 17295654 DOI: 10.1111/j.1440-1797.2006.00703.x  0.353
2007 Yang SS, Fu LS, Chang CS, Yeh HZ, Chen GH, Kao JH. Changes of soluble CD26 and CD30 levels correlate with response to interferon plus ribavirin therapy in patients with chronic hepatitis C. Journal of Gastroenterology and Hepatology. 21: 1789-93. PMID 17074015 DOI: 10.1111/j.1440-1746.2006.04677.x  0.328
2007 Liu CH, Lin JW, Tsai FC, Yang PM, Lai MY, Chen JH, Kao JH, Chen DS. Noninvasive tests for the prediction of significant hepatic fibrosis in hepatitis C virus carriers with persistently normal alanine aminotransferases. Liver International : Official Journal of the International Association For the Study of the Liver. 26: 1087-94. PMID 17032409 DOI: 10.1111/j.1478-3231.2006.01355.x  0.384
2007 Liu CJ, Chen PJ, Lai MY, Lin FY, Wang T, Kao JH, Chen DS. Viral factors correlate with hepatitis B e antigen seroconverson in patients with chronic hepatitis B. Liver International : Official Journal of the International Association For the Study of the Liver. 26: 949-55. PMID 16953835 DOI: 10.1111/j.1478-3231.2006.01319.x  0.389
2007 Lin CL, Kao JH. Hepatitis B viral load as a prognostic factor for patients with unresectable hepatocellular carcinoma Future Virology. 2: 441-443. DOI: 10.2217/17460794.2.5.441  0.383
2007 Kao JH. Appropriate use of interferon for treatment of chronic hepatitis B Hepatology Research. 37. DOI: 10.1111/j.1872-034X.2007.00105.x  0.412
2007 Lin CL, Kao JH. Intrafamilial transmission of hepatitis B virus infection [3] Journal of Gastroenterology and Hepatology (Australia). 22: 765-766. DOI: 10.1111/j.1440-1746.2007.04825.x  0.352
2007 Liu C, Chen P, Kao J, Lai M, Chen C, Liu C, Chen D, Yu M, Dai C, Lin Y, Chuang W, Lu S, Wang J, Hu T, Hung C, et al. [610] AN OPEN-LABEL, COMPARATIVE, MULTICENTER STUDY OF PEGINTERFERON a-2a PLUS RIBAVIRIN FOR CHRONIC HEPATITIS C/HEPATITIS B CO-INFECTION VERSUS CHRONIC HEPATITIS C MONOINFECTION: AN INTERIM REPORT Journal of Hepatology. 46: S231. DOI: 10.1016/S0168-8278(07)62208-9  0.393
2007 Liu CJ, Kao JH. Hepatitis B virus genotype: What should the clinician know? Current Hepatitis Reports. 6: 17-23. DOI: 10.1007/BF02942174  0.387
2006 Liu CJ, Kao JH. Pegylated interferons for the treatment of chronic hepatitis B Recent Patents On Anti-Infective Drug Discovery. 1: 85-94. PMID 18221137 DOI: 10.2174/157489106775244154  0.348
2006 Liu CJ, Kao JH, Chen DS. Kinetics of Hepatitis B Virus Reactivation After Chemotherapy: More Questions Than Answers Gastroenterology. 131: 1656. PMID 17101335 DOI: 10.1053/j.gastro.2006.10.005  0.346
2006 Tong MJ, Blatt LM, Kao JH, Cheng JT, Corey WG. Precore/basal core promoter mutants and hepatitis B viral DNA levels as predictors for liver deaths and hepatocellular carcinoma World Journal of Gastroenterology. 12: 6620-6626. PMID 17075974 DOI: 10.3748/WJG.V12.I41.6620  0.344
2006 Huang YW, Liu CJ, Lai MY, Lee PH, Tsai MK, Wang SS, Lai MK, Kao JH. Discontinuation of lamivudine treatment for hepatitis flare after kidney or heart transplantation in hepatitis B surface antigen-positive patients: A retrospective case series. Clinical Therapeutics. 28: 1327-34. PMID 17062306 DOI: 10.1016/j.clinthera.2006.09.011  0.39
2006 Liu CJ, Kao JH, Chen DS. Mixed hepatitis B virus genotype infections: The more, the worse? [3] Hepatology. 44: 770. PMID 16941677 DOI: 10.1002/hep.21342  0.373
2006 Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, Chen DS. Role of hepatitis B virus precore/core promoter mutations and serum viral load on noncirrhotic hepatocellular carcinoma: a case-control study. The Journal of Infectious Diseases. 194: 594-9. PMID 16897657 DOI: 10.1086/505883  0.345
2006 Huang YW, Lin CL, Chen PJ, Lai MY, Kao JH, Chen DS. Higher cut-off index value of immunoglobulin M antibody to hepatitis B core antigen in Taiwanese patients with hepatitis B. Journal of Gastroenterology and Hepatology. 21: 859-62. PMID 16704536 DOI: 10.1111/j.1440-1746.2006.04280.x  0.313
2006 Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases. Gastroenterology. 130: 1153-68. PMID 16618410 DOI: 10.1053/J.GASTRO.2006.01.011  0.364
2006 Liu CH, Chen BF, Chen SC, Lai MY, Kao JH, Chen DS. Selective transmission of hepatitis C virus quasi species through a needlestick accident in acute resolving hepatitis. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 42: 1254-9. PMID 16586384 DOI: 10.1086/503040  0.363
2006 Liu CJ, Chen BF, Chen PJ, Lai MY, Huang WL, Kao JH, Chen DS. Role of hepatitis B viral load and basal core promoter mutation in hepatocellular carcinoma in hepatitis B carriers. The Journal of Infectious Diseases. 193: 1258-65. PMID 16586363 DOI: 10.1086/502978  0.37
2006 Liu CJ, Lai MY, Chao YC, Liao LY, Yang SS, Hsiao TJ, Hsieh TY, Lin CL, Hu JT, Chen CL, Chen PJ, Kao JH, Chen DS. Interferon alpha-2b with and without ribavirin in the treatment of hepatitis B e antigen-positive chronic hepatitis B: a randomized study. Hepatology (Baltimore, Md.). 43: 742-9. PMID 16557544 DOI: 10.1002/hep.21100  0.358
2006 Liu CJ, Kao JH, Chen DS. Clinical significance of occult hepatitis B virus infection cannot be overlooked [11] Clinical Infectious Diseases. 42: 583-584. PMID 16421814 DOI: 10.1086/500016  0.35
2006 Chen BF, Liu CJ, Jow GM, Chen PJ, Kao JH, Chen DS. Evolution of Hepatitis B virus in an acute hepatitis B patient co-infected with genotypes B and C. The Journal of General Virology. 87: 39-49. PMID 16361416 DOI: 10.1099/vir.0.81357-0  0.332
2006 Liu CJ, Lo SC, Kao JH, Tseng PT, Lai MY, Ni YH, Yeh SH, Chen PJ, Chen DS. Transmission of occult hepatitis B virus by transfusion to adult and pediatric recipients in Taiwan. Journal of Hepatology. 44: 39-46. PMID 16168517 DOI: 10.1016/j.jhep.2005.06.016  0.361
2006 Kao JH, Chen DS. HBV genotypes: Epidemiology and implications regarding natural history Current Hepatitis Reports. 5: 5-13. DOI: 10.1007/s11901-006-0017-9  0.388
2005 Liu CJ, Kao JH, Chen DS. Therapeutic implications of hepatitis B virus genotypes Liver International. 25: 1097-1107. PMID 16343058 DOI: 10.1111/j.1478-3231.2005.01177.x  0.406
2005 Lin CL, Kao JH, Chen BF, Chen PJ, Lai MY, Chen DS. Application of hepatitis B virus genotyping and phylogenetic analysis in intrafamilial transmission of hepatitis B virus. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 41: 1576-81. PMID 16267729 DOI: 10.1086/497837  0.358
2005 Liu CJ, Kao JH, Chan HLY. Subgenotypes of hepatitis B virus genotype C in Taiwan [3] (multiple letters) Journal of Infectious Diseases. 192: 1308-1309. PMID 16136480 DOI: 10.1086/444470  0.376
2005 Lu JY, Chuang LM, Yang WS, Tai TY, Lai MY, Chen PJ, Kao JH, Lee CZ, Lee HS. Adiponectin levels among patients with chronic hepatitis B and C infections and in response to IFN-alpha therapy. Liver International : Official Journal of the International Association For the Study of the Liver. 25: 752-9. PMID 15998426 DOI: 10.1111/j.1478-3231.2005.1007.x  0.303
2005 Kao JH, Chen DS. Changing disease burden of hepatocellular carcinoma in the Far East and Southeast Asia Liver International. 25: 696-703. PMID 15998418 DOI: 10.1111/j.1478-3231.2005.01139.x  0.389
2005 Liu CJ, Chen PJ, Jeng YM, Huang WL, Yang WS, Lai MY, Kao JH, Chen DS. Serum adiponectin correlates with viral characteristics but not histologic features in patients with chronic hepatitis C. Journal of Hepatology. 43: 235-42. PMID 15964656 DOI: 10.1016/j.jhep.2005.02.044  0.343
2005 Lin CL, Liao LY, Wang CS, Chen PJ, Lai MY, Chen DS, Kao JH. Basal core-promoter mutant of hepatitis B virus and progression of liver disease in hepatitis B e antigen-negative chronic hepatitis B. Liver International : Official Journal of the International Association For the Study of the Liver. 25: 564-70. PMID 15910494 DOI: 10.1111/j.1478-3231.2005.01041.x  0.419
2005 Liaw YF, Leung N, Guan R, Lau GK, Merican I, McCaughan G, Gane E, Kao JH, Omata M. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update. Liver International : Official Journal of the International Association For the Study of the Liver. 25: 472-89. PMID 15910483 DOI: 10.1111/j.1478-3231.2005.01134.x  0.353
2005 Mah YH, Kao JH, Liu CJ, Chen CL, Chen PJ, Lai MY, Chen DS. Prevalence and clinical implications of HFE gene mutations (C282Y and H63D) in patients with chronic hepatitis B and C in Taiwan. Liver International : Official Journal of the International Association For the Study of the Liver. 25: 214-9. PMID 15780041 DOI: 10.1111/j.1478-3231.2005.01055.x  0.329
2005 Yu MW, Yeh SH, Chen PJ, Liaw YF, Lin CL, Liu CJ, Shih WL, Kao JH, Chen DS, Chen CJ. Hepatitis B virus genotype and DNA level and hepatocellular carcinoma: a prospective study in men. Journal of the National Cancer Institute. 97: 265-72. PMID 15713961 DOI: 10.1093/jnci/dji043  0.387
2005 Peng YS, Chiang CK, Hsu SP, Pai MF, Hung KY, Kao JH. Influence of hepatitis C virus infection on soluble cellular adhesion molecules in hemodialysis patients. Blood Purification. 23: 106-12. PMID 15640602 DOI: 10.1159/000083204  0.332
2005 Chen BF, Chen PJ, Jow GM, Sablon E, Liu CJ, Chen DS, Kao JH. High prevalence of mixed genotype infections in hepatitis B virus infected intravenous drug users. Journal of Medical Virology. 74: 536-42. PMID 15484267 DOI: 10.1002/JMV.20211  0.33
2004 Ni YH, Chang MH, Wang KJ, Hsu HY, Chen HL, Kao JH, Yeh SH, Jeng YM, Tsai KS, Chen DS. Clinical relevance of hepatitis B virus genotype in children with chronic infection and hepatocellular carcinoma. Gastroenterology. 127: 1733-8. PMID 15578511 DOI: 10.1053/j.gastro.2004.09.048  0.388
2004 Yeh SH, Tsai CY, Kao JH, Liu CJ, Kuo TJ, Lin MW, Huang WL, Lu SF, Jih J, Chen DS, Chen PJ. Quantification and genotyping of hepatitis B virus in a single reaction by real-time PCR and melting curve analysis Journal of Hepatology. 41: 659-666. PMID 15464248 DOI: 10.1016/j.jhep.2004.06.031  0.376
2004 Liu CJ, Kao JH, Wang HY, Lai MY, Chen TC, Chen PJ, Chen DS. Origin of serum hepatitis B virus in acute exacerbation: Comparison with HBV in the liver and from other exacerbation Hepatology. 40: 310-317. PMID 15368435 DOI: 10.1002/hep.20331  0.348
2004 Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. Evolution of precore/core promoter mutations in hepatitis B carriers with hepatitis B e antigen seroreversion. Journal of Medical Virology. 74: 237-45. PMID 15332272 DOI: 10.1002/JMV.20176  0.323
2004 Lin CL, Liao LY, Wang CS, Chen PJ, Lai MY, Chen DS, Kao JH. Evolution of hepatitis B virus precore/basal core promoter gene in HBeAg-positive chronic hepatitis B patients receiving lamivudine therapy. Liver International : Official Journal of the International Association For the Study of the Liver. 24: 9-15. PMID 15101995 DOI: 10.1111/j.1478-3231.2004.00893.x  0.417
2004 Chen BF, Kao JH, Liu CJ, Chen DS, Chen PJ. Genotypic Dominance and Novel Recombinations in HBV Genotype B and C Co-Infected Intravenous Drug Users Journal of Medical Virology. 73: 13-22. PMID 15042642 DOI: 10.1002/jmv.20051  0.345
2004 Chen JD, Liu CJ, Lee PH, Chen PJ, Lai MY, Kao JH, Chen DS. Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma. Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association. 2: 64-71. PMID 15017634 DOI: 10.1016/S1542-3565(03)00293-3  0.35
2004 Yang SS, Lai MY, Chen DS, Chen GH, Kao JH. Mutations in the NS5A and E2-PePHD regions of hepatitis C virus genotype 1b and response to combination therapy of interferon plus ribavirin. Liver International : Official Journal of the International Association For the Study of the Liver. 23: 426-33. PMID 14986817 DOI: 10.1111/j.1478-3231.2003.00875.x  0.371
2004 Liu CJ, Kao JH, Lai MY, Chen PJ, Chen DS. Precore/core promoter mutations and genotypes of hepatitis B virus in chronic hepatitis B patients with fulminant or subfulminant hepatitis. Journal of Medical Virology. 72: 545-50. PMID 14981756 DOI: 10.1002/JMV.20024  0.379
2004 Kao JH, Chen DS, Lok ASF. Hepatitis B Virus Genotypes and Core Promoter Variant [10] (multiple letters) Gastroenterology. 126: 633. PMID 14765403 DOI: 10.1053/j.gastro.2003.12.037  0.359
2004 Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis B Virus Genotypes and Spontaneous Hepatitis B e Antigen Seroconversion in Taiwanese Hepatitis B Carriers Journal of Medical Virology. 72: 363-369. PMID 14748059 DOI: 10.1002/jmv.10534  0.387
2003 Kao JH, Chen DS, Sugauchi F, Miyakawa Y, Mizokami M. Clinical Relevance of Hepatitis B Virus Genotypes Ba and Bj in Taiwan [6] (multiple letters) Gastroenterology. 125: 1916-1918. PMID 14727634 DOI: 10.1053/j.gastro.2003.05.014  0.355
2003 Kao JH. Hepatitis B virus genotypes and hepatocellular carcinoma in Taiwan Intervirology. 46: 400-407. PMID 14688459 DOI: 10.1159/000074999  0.419
2003 Liu CJ, Kao JH, Chen DS. Molecular Assays for Hepatitis B Virus Infection [1] Hepatology. 38: 1311. PMID 14578872 DOI: 10.1053/jhep.2003.50456  0.352
2003 Liu CJ, Chen PJ, Shau WY, Kao JH, Lai MY, Chen DS. Clinical aspects and outcomes of volunteer blood donors testing positive for hepatitis-C virus infection in Taiwan: a prospective study. Liver International : Official Journal of the International Association For the Study of the Liver. 23: 148-55. PMID 12955877 DOI: 10.1034/j.1600-0676.2003.00820.x  0.383
2003 Liu CJ, Chen PJ, Lai MY, Kao JH, Jeng YM, Chen DS. Ribavirin and interferon is effective for hepatitis C virus clearance in hepatitis B and C dually infected patients. Hepatology (Baltimore, Md.). 37: 568-76. PMID 12601355 DOI: 10.1053/JHEP.2003.50096  0.427
2003 Kao JH, Chen PJ, Lai MY, Chen DS. Basal core promoter mutations of hepatitis B virus increase the risk of hepatocellular carcinoma in hepatitis B carriers Gastroenterology. 124: 327-334. PMID 12557138 DOI: 10.1053/gast.2003.50053  0.343
2003 Liu CJ, Chen PJ, Lai MY, Kao JH, Chang CF, Wu HL, Shau WY, Chen DS. A prospective study characterizing full-length hepatitis B virus genomes during acute exacerbation. Gastroenterology. 124: 80-90. PMID 12512032 DOI: 10.1053/GAST.2003.50003  0.394
2003 Liu CJ, Kao JH, Chen PJ, Lai MY, Chen DS. Molecular epidemiology of hepatitis B viral serotypes and genotypes in taiwan. Journal of Biomedical Science. 9: 166-70. PMID 11914584 DOI: 10.1007/BF02256028  0.363
2002 Kao JH, Chen W, Chen PJ, Lai MY, Chen DS. SEN virus infection in patients with chronic hepatitis C: preferential coinfection with hepatitis C genotype 2a and no effect on response to therapy with interferon plus ribavirin. The Journal of Infectious Diseases. 187: 307-10. PMID 12552456 DOI: 10.1086/346055  0.376
2002 Kao JH, Chen PJ, Lai MY, Chen DS. Occult hepatitis B virus infection and clinical outcomes of patients with chronic hepatitis C Journal of Clinical Microbiology. 40: 4068-4071. PMID 12409376 DOI: 10.1128/JCM.40.11.4068-4071.2002  0.457
2002 Liu CJ, Kao JH, Shau WY, Chen PJ, Lai MY, Chen DS. Naturally occurring hepatitis B surface gene variants in chronic hepatitis B virus infection: correlation with viral serotypes and clinical stages of liver disease. Journal of Medical Virology. 68: 50-9. PMID 12210430 DOI: 10.1002/JMV.10169  0.341
2002 Kao JH, Chen PJ, Lai MY, Chen DS. Sequence analysis of pre-S/surface and pre-core/core promoter genes of hepatitis B virus in chronic hepatitis C patients with occult HBV infection Journal of Medical Virology. 68: 216-220. PMID 12210410 DOI: 10.1002/jmv.10188  0.426
2002 Kao JH, Chen PJ, Lai MY, Chen DS. Hepatitis D virus genotypes in intravenous drug users in Taiwan: Decreasing prevalence and lack of correlation with hepatitis B virus genotypes Journal of Clinical Microbiology. 40: 3047-3049. PMID 12149376 DOI: 10.1128/JCM.40.8.3047-3049.2002  0.357
2002 Kao JH, Chen DS. Global control of hepatitis B virus infection Lancet Infectious Diseases. 2: 395-403. PMID 12127351 DOI: 10.1016/S1473-3099(02)00315-8  0.394
2002 Kao JH. Hepatitis B viral genotypes: Clinical relevance and molecular characteristics Journal of Gastroenterology and Hepatology (Australia). 17: 643-650. PMID 12100608 DOI: 10.1046/j.1440-1746.2002.02737.x  0.432
2002 Lin CL, Liao LY, Liu CJ, Chen PJ, Lai MY, Kao JH, Chen DS. Hepatitis B genotypes and precore/basal core promoter mutants in HBeAg-negative chronic hepatitis B. Journal of Gastroenterology. 37: 283-7. PMID 11993512 DOI: 10.1007/s005350200036  0.389
2002 Kao JH, Chen PJ, Lai MY, Chen DS. Genotypes and clinical phenotypes of hepatitis B virus in patients with chronic hepatitis B virus infection Journal of Clinical Microbiology. 40: 1207-1209. PMID 11923332 DOI: 10.1128/JCM.40.4.1207-1209.2002  0.393
2002 Kao JH, Liu CJ, Chen DS. Hepatitis B viral genotypes and lamivudine resistance [1] Journal of Hepatology. 36: 303-304. PMID 11830346 DOI: 10.1016/S0168-8278(01)00246-X  0.34
2002 Kao JH, Chen W, Chen PJ, Lai MY, Chen DS. Prevalence and implication of a newly identified infectious agent (SEN virus) in Taiwan. The Journal of Infectious Diseases. 185: 389-92. PMID 11807722 DOI: 10.1086/338472  0.349
2002 Kao JH, Chen PJ, Lai MY, Chen DS. Clinical and virological aspects of blood donors infected with hepatitis B virus genotypes B and C Journal of Clinical Microbiology. 40: 22-25. PMID 11773087 DOI: 10.1128/JCM.40.1.22-25.2002  0.353
2002 Kao JH. Clinical relevance of hepatitis B viral genotypes: A case of déjà vu? Journal of Gastroenterology and Hepatology (Australia). 17: 113-115. DOI: 10.1046/j.1440-1746.2002.02623.x  0.338
2002 Yang H, Lai M, Chen P, Kao J, Chen D. The effect of interferon plus ribavirin or interferon alone on the development of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis C Journal of Hepatology. 36: 250. DOI: 10.1016/S0168-8278(02)80900-X  0.366
2002 Chen P, Liu C, Kao J, Lai M, Chen D. Interferon and ribavirin combination therapy clears HCV in hepatitis B and C co-infection patients as effectively as in simple hepatitis C: a pilot study Journal of Hepatology. 36: 174. DOI: 10.1016/S0168-8278(02)80615-8  0.408
2002 King JK, Yeh S, Lin M, Liu C, Lai M, Kao J, Chen D, Chen P. Genetic polymorphisms in interferon pathway and response to interferon treatment in hepatitis B patients: A pilot study Hepatology. 36: 1416-1424. DOI: 10.1002/hep.1840360618  0.301
2001 Kao JH, Chen PJ, Lai MY, Chen DS. Acute exacerbations of chronic hepatitis B are rarely associated with superinfection of hepatitis B virus Hepatology. 34: 817-823. PMID 11584381 DOI: 10.1053/jhep.2001.28188  0.416
2000 Kao JH, Chen W, Chen PJ, Lai MY, Chen DS. Liver and peripheral blood mononuclear cells are not major sites for GB virus-C/hepatitis G virus replication. Archives of Virology. 144: 2173-83. PMID 10603171 DOI: 10.1007/s007050050631  0.305
1999 Pu YS, Liu CM, Kao JH, Chen J, Lai MK. Antiandrogen hepatotoxicity in patients with chronic viral hepatitis. European Urology. 36: 293-7. PMID 10473987 DOI: 10.1159/000020007  0.382
1999 Kao JH, Chen DS. GB virus-C/hepatitis G virus infection in Taiwan: A virus that fails to cause a disease? Journal of Biomedical Science. 6: 220-225. PMID 10420079 DOI: 10.1007/BF02253563  0.331
1999 Kao JH, Huang CH, Chen W, Tsai TJ, Lee SH, Hung KY, Chen DS. GB virus C infection in hemodialysis patients: molecular evidence for nosocomial transmission. The Journal of Infectious Diseases. 180: 191-4. PMID 10353878 DOI: 10.1086/314850  0.335
1998 Kao JH, Hwang JJ. Hepatitis C virus infection and chronic active myocarditis. Circulation. 98: 1044-5. PMID 9737529 DOI: 10.1161/01.CIR.98.10.1044  0.352
1998 Kao JH, Chen PJ, Lai MY, Chen W, Chen DS. Effects of GB virus-C/hepatitis G virus on hepatitis B and C viremia in multiple hepatitis virus infections. Archives of Virology. 143: 797-802. PMID 9638149 DOI: 10.1007/s007050050331  0.399
1997 Kao JH, Chen PJ, Lai MY, Wang TH, Chen DS. Positive and negative strand of hepatitis C virus RNA sequences in peripheral blood mononuclear cells in patients with chronic hepatitis C: No correlation with viral genotypes 1b, 2a, and 2b Journal of Medical Virology. 52: 270-274. PMID 9210035 DOI: 10.1002/(SICI)1096-9071(199707)52:3<270::AID-JMV6>3.0.CO;2-#  0.365
1996 Kao JH, Chen PJ, Chen DS. GBV-C in the aetiology of fulminant hepatitis. Lancet (London, England). 347: 120-1. PMID 8538315 DOI: 10.1016/S0140-6736(96)90244-5  0.332
1995 Kao JH, Chen PJ, Lai MY, Wang TH, Chen DS. Quasispecies of hepatitis c virus and genetic drift of the hypervariable region in chronic type c hepatitis Journal of Infectious Diseases. 172: 261-264. PMID 7797927 DOI: 10.1093/infdis/172.1.261  0.363
1993 Chen PJ, Hwang LH, Chang LY, Kao JH, Chen DS. Immunoglobulin M antibodies against hepatitis C virus antigens: significance and applications Gastroenterologia Japonica. 28: 67-70. PMID 7689510 DOI: 10.1007/BF02989209  0.333
1993 KAO J. Hepatitis C antibody and viral RNA profile in patients with chronic non-A, non-B hepatitis and the relationship to liver disease Hepatology. 18: A240. DOI: 10.1016/0270-9139(93)92483-G  0.369
Show low-probability matches.